<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE sequence-cwu SYSTEM "us-sequence-listing-v1_3-2020-10-08.dtd" [ ]><sequence-cwu id="SEQLST-1"><publication-reference><document-id><country>US</country><doc-number>20230002777</doc-number><kind>A1</kind><date>20230105</date></document-id></publication-reference><number>1</number><sequence-list-new-rules><s100><s160>198</s160></s100><s200><s210>1</s210><s211>75</s211><s212>PRT</s212><s213>Bacillus subtilis</s213></s200><s400> 1Met Asn Gln Lys His Ser Ser Asp Phe Val Val Ile Lys Ala Val Glu1               5                   10                  15Asp Gly Val Asn Val Ile Gly Leu Thr Arg Gly Thr Asp Thr Lys Phe            20                  25                  30His His Ser Glu Lys Leu Asp Lys Gly Glu Val Ile Ile Ala Gln Phe        35                  40                  45Thr Glu His Thr Ser Ala Ile Lys Val Arg Gly Glu Ala Leu Ile Gln    50                  55                  60Thr Ala Tyr Gly Glu Met Lys Ser Glu Lys Lys65                  70                  75</s400><s200><s210>2</s210><s211>86</s211><s212>PRT</s212><s213>Aminomonas paucivorans</s213></s200><s400> 2Met Lys Glu Gly Glu Glu Ala Lys Thr Ser Val Leu Ser Asp Tyr Val1               5                   10                  15Val Val Lys Ala Leu Glu Asn Gly Val Thr Val Ile Gly Leu Thr Arg            20                  25                  30Gly Gln Glu Thr Lys Phe Ala His Thr Glu Lys Leu Asp Asp Gly Glu        35                  40                  45Val Trp Ile Ala Gln Phe Thr Glu His Thr Ser Ala Ile Lys Val Arg    50                  55                  60Gly Ala Ser Glu Ile His Thr Lys His Gly Met Leu Phe Ser Gly Arg65                  70                  75                  80Gly Arg Asn Glu Lys Gly                85</s400><s200><s210>3</s210><s211>81</s211><s212>PRT</s212><s213>Desulfotomaculum hydrothermale</s213></s200><s400> 3Met Asn Pro Met Thr Asp Arg Ser Asp Ile Thr Gly Asp Tyr Val Val1               5                   10                  15Val Lys Ala Leu Glu Asn Gly Val Thr Ile Ile Gly Leu Thr Arg Gly            20                  25                  30Gly Val Thr Lys Phe His His Thr Glu Lys Leu Asp Lys Gly Glu Ile        35                  40                  45Met Ile Ala Gln Phe Thr Glu His Thr Ser Ala Ile Lys Ile Arg Gly    50                  55                  60Arg Ala Glu Leu Leu Thr Lys His Gly Lys Ile Arg Thr Glu Val Asp65                  70                  75                  80Ser</s400><s200><s210>4</s210><s211>74</s211><s212>PRT</s212><s213>Bacillus stearothermophilus</s213></s200><s400> 4Met Tyr Thr Asn Ser Asp Phe Val Val Ile Lys Ala Leu Glu Asp Gly1               5                   10                  15Val Asn Val Ile Gly Leu Thr Arg Gly Ala Asp Thr Arg Phe His His            20                  25                  30Ser Glu Lys Leu Asp Lys Gly Glu Val Leu Ile Ala Gln Phe Thr Glu        35                  40                  45His Thr Ser Ala Ile Lys Val Arg Gly Lys Ala Tyr Ile Gln Thr Arg    50                  55                  60His Gly Val Ile Glu Ser Glu Gly Lys Lys65                  70</s400><s200><s210>5</s210><s211>74</s211><s212>PRT</s212><s213>Bacillus stearothermophilus</s213></s200><s400> 5Met Tyr Thr Asn Ser Asp Phe Val Val Ile Lys Ala Leu Glu Asp Gly1               5                   10                  15Val Asn Val Ile Gly Leu Thr Arg Gly Ala Asp Thr Arg Phe His His            20                  25                  30Ser Glu Lys Leu Asp Lys Gly Glu Val Leu Ile Ala Gln Phe Thr Glu        35                  40                  45His Thr Ser Ala Ile Lys Val Arg Gly Lys Ala Tyr Ile Gln Thr Arg    50                  55                  60His Gly Val Ile Glu Asn Glu Gly Lys Lys65                  70</s400><s200><s210>6</s210><s211>76</s211><s212>PRT</s212><s213>Bacillus halodurans</s213></s200><s400> 6Met Asn Val Gly Asp Asn Ser Asn Phe Phe Val Ile Lys Ala Lys Glu1               5                   10                  15Asn Gly Val Asn Val Phe Gly Met Thr Arg Gly Thr Asp Thr Arg Phe            20                  25                  30His His Ser Glu Lys Leu Asp Lys Gly Glu Val Met Ile Ala Gln Phe        35                  40                  45Thr Glu His Thr Ser Ala Val Lys Ile Arg Gly Lys Ala Ile Ile Gln    50                  55                  60Thr Ser Tyr Gly Thr Leu Asp Thr Glu Lys Asp Glu65                  70                  75</s400><s200><s210>7</s210><s211>80</s211><s212>PRT</s212><s213>Carboxydothermus hydrogenoformans</s213></s200><s400> 7Met Val Cys Asp Asn Phe Ala Phe Ser Ser Ala Ile Asn Ala Glu Tyr1               5                   10                  15Ile Val Val Lys Ala Leu Glu Asn Gly Val Thr Ile Met Gly Leu Thr            20                  25                  30Arg Gly Lys Asp Thr Lys Phe His His Thr Glu Lys Leu Asp Lys Gly        35                  40                  45Glu Val Met Val Ala Gln Phe Thr Glu His Thr Ser Ala Ile Lys Ile    50                  55                  60Arg Gly Lys Ala Glu Ile Tyr Thr Lys His Gly Val Ile Lys Asn Glu65                  70                  75                  80</s400><s200><s210>8</s210><s211>55</s211><s212>RNA</s212><s213>Artificial Sequence</s213><s220><s223>TRAP binding site variant</s223></s220></s200><s400> 8gaguuuagcg gaguggagaa gagcggagcc gagccuagca gagacgagug gagcu          55</s400><s200><s210>9</s210><s211>55</s211><s212>RNA</s212><s213>Artificial Sequence</s213><s220><s223>TRAP binding site variant</s223></s220></s200><s400> 9gaguuuagcg gaguggagaa gagcggagcc gagccuagca gagacgagaa gagcu          55</s400><s200><s210>10</s210><s211>30</s211><s212>RNA</s212><s213>Artificial Sequence</s213><s220><s223>TRAP binding site variant</s223></s220></s200><s400> 10uaguuuaguu uaguuuaguu uaguuuaguu                                      30</s400><s200><s210>11</s210><s211>30</s211><s212>RNA</s212><s213>Artificial Sequence</s213><s220><s223>TRAP binding site variant</s223></s220></s200><s400> 11uaguuuaguu gaguuuaguu gaguuuaguu                                      30</s400><s200><s210>12</s210><s211>32</s211><s212>RNA</s212><s213>Artificial Sequence</s213><s220><s223>TRAP binding site variant</s223></s220></s200><s400> 12gaguuugagu ugaguugagu uugaguugag uu                                   32</s400><s200><s210>13</s210><s211>32</s211><s212>RNA</s212><s213>Artificial Sequence</s213><s220><s223>TRAP binding site variant</s223></s220></s200><s400> 13uaguuugagu uuaguugagu uuuaguugag uu                                   32</s400><s200><s210>14</s210><s211>55</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>TRAP binding site variant</s223></s220></s200><s400> 14gagtttagcg gagtggagaa gagcggagcc gagcctagca gagacgagtg gagct          55</s400><s200><s210>15</s210><s211>50</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>TRAP binding site variant</s223></s220></s200><s400> 15gagtttagcg gagtggagaa gagcggagcc gagcctagca gagacgagaa                50</s400><s200><s210>16</s210><s211>45</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>TRAP binding site variant</s223></s220></s200><s400> 16gagtttagcg gagtggagaa gagcggagcc gagcctagca gagac                     45</s400><s200><s210>17</s210><s211>40</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>TRAP binding site variant</s223></s220></s200><s400> 17gagtttagcg gagtggagaa gagcggagcc gagcctagca                           40</s400><s200><s210>18</s210><s211>35</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>TRAP binding site variant</s223></s220></s200><s400> 18gagtttagcg gagtggagaa gagcggagcc gagcc                                35</s400><s200><s210>19</s210><s211>30</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>TRAP binding site variant</s223></s220></s200><s400> 19gagtttagcg gagtggagaa gagcggagcc                                      30</s400><s200><s210>20</s210><s211>58</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>TRAP binding site variant</s223></s220></s200><s400> 20gagtttagcg gagtggagaa agagacggag ccgagaccta gcagagacga gaagagct       58</s400><s200><s210>21</s210><s211>56</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>TRAP binding site variant</s223></s220></s200><s400> 21gagtttagcg gagtggagaa gagacggagc cgagcctagc agagacgaga agagct         56</s400><s200><s210>22</s210><s211>55</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>TRAP binding site variant</s223></s220></s200><s400> 22gagtttagcg gagtggagaa gagcggagcc gagcctagca gagacgagaa gagct          55</s400><s200><s210>23</s210><s211>41</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>TRAP binding site variant</s223></s220></s200><s400> 23gagtttagcg gagtggagaa agagcggagc cgagcctagc a                         41</s400><s200><s210>24</s210><s211>36</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>TRAP binding site variant</s223></s220></s200><s400> 24gagtttagcg gagtggagaa agagcggagc cgagcc                               36</s400><s200><s210>25</s210><s211>33</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>L33 Improved leader sequence</s223></s220></s200><s400> 25ctttttcgca acgggtttgc cgccagaaca cag                                  33</s400><s200><s210>26</s210><s211>12</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>L12 Improved leader sequence</s223></s220></s200><s400> 26ctttttcgca ac                                                         12</s400><s200><s210>27</s210><s211>10</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>extended Kozak consensus sequence</s223></s220><s220><s221>misc_feature</s221><s222>(2)..(3)</s222><s223>n is a, c, g, or t</s223></s220></s200><s400> 27gnnrvvatgg                                                            10</s400><s200><s210>28</s210><s211>6</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>core Kozak consensus sequence</s223></s220></s200><s400> 28rvvatg                                                                 6</s400><s200><s210>29</s210><s211>6</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>3&#x2032; tbs-Kozak junction variant</s223></s220></s200><s400> 29gagatg                                                                 6</s400><s200><s210>30</s210><s211>7</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>3&#x2032; tbs-Kozak junction variant</s223></s220></s200><s400> 30kagvatg                                                                7</s400><s200><s210>31</s210><s211>8</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>3&#x2032; tbs-Kozak junction variant</s223></s220></s200><s400> 31kagvvatg                                                               8</s400><s200><s210>32</s210><s211>9</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>3&#x2032; tbs-Kozak junction variant</s223></s220></s200><s400> 32kagrvvatg                                                              9</s400><s200><s210>33</s210><s211>10</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>3&#x2032; tbs-Kozak junction variant</s223></s220><s220><s221>misc_feature</s221><s222>(4)..(4)</s222><s223>n is a, c, g, or t</s223></s220></s200><s400> 33kagnrvvatg                                                            10</s400><s200><s210>34</s210><s211>11</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>optimal 3&#x2032; tbs-Kozak junction variant</s223></s220></s200><s400> 34kagccgagat g                                                          11</s400><s200><s210>35</s210><s211>13</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>optimal 3&#x2032; tbs-Kozak junction variant</s223></s220><s220><s221>misc_feature</s221><s222>(4)..(4)</s222><s223>n is a, c, g, or t</s223></s220></s200><s400> 35kagnggagcc atg                                                        13</s400><s200><s210>36</s210><s211>14</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>optimal 3&#x2032; tbs-Kozak junction variant</s223></s220><s220><s221>misc_feature</s221><s222>(4)..(5)</s222><s223>n is a, c, g, or t</s223></s220></s200><s400> 36kagnngagac catg                                                       14</s400><s200><s210>37</s210><s211>12</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>3&#x2032; tbs-Kozak junction variant</s223></s220></s200><s400> 37kaggcgagca tg                                                         12</s400><s200><s210>38</s210><s211>15</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>spacer variant</s223></s220></s200><s400> 38atagcagaga cggct                                                      15</s400><s200><s210>39</s210><s211>10</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>spacer variant</s223></s220></s200><s400> 39atagcagaga                                                            10</s400><s200><s210>40</s210><s211>5</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>spacer variant</s223></s220></s200><s400> 40atagc                                                                  5</s400><s200><s210>41</s210><s211>26</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>spacer variant</s223></s220></s200><s400> 41atatcagaga cggctagcgt atacca                                          26</s400><s200><s210>42</s210><s211>15</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>spacer variant</s223></s220></s200><s400> 42atatcagaga cggct                                                      15</s400><s200><s210>43</s210><s211>10</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>spacer variant</s223></s220></s200><s400> 43agagacggct                                                            10</s400><s200><s210>44</s210><s211>5</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>spacer variant</s223></s220></s200><s400> 44tacca                                                                  5</s400><s200><s210>45</s210><s211>15</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>3&#x2032; tbs-MCS-Kozak variant</s223></s220></s200><s400> 45gagctctaga vvatg                                                      15</s400><s200><s210>46</s210><s211>16</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>3&#x2032; tbs-MCS-Kozak variant</s223></s220></s200><s400> 46gagctcgtcg acvatg                                                     16</s400><s200><s210>47</s210><s211>20</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>3&#x2032; tbs-MCS-Kozak variant</s223></s220></s200><s400> 47gagctcgaat tcgaavvatg                                                 20</s400><s200><s210>48</s210><s211>21</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>3&#x2032; tbs-MCS-Kozak variant</s223></s220></s200><s400> 48gagctctaga cgtcgacvat g                                               21</s400><s200><s210>49</s210><s211>22</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>3&#x2032; tbs-MCS-Kozak variant</s223></s220></s200><s400> 49gagctctaga attcgaavva tg                                              22</s400><s200><s210>50</s210><s211>23</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>3&#x2032; tbs-MCS-Kozak variant</s223></s220></s200><s400> 50gagctctaga tatcgatrvv atg                                             23</s400><s200><s210>51</s210><s211>25</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>3&#x2032; tbs-MCS-Kozak variant</s223></s220></s200><s400> 51kagactagta cttaagcttr vvatg                                           25</s400><s200><s210>52</s210><s211>15</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>3&#x2032; tbs-MCS-Kozak variant</s223></s220></s200><s400> 52gagctctaga ccatg                                                      15</s400><s200><s210>53</s210><s211>16</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>3&#x2032; tbs-MCS-Kozak variant</s223></s220></s200><s400> 53gagctcgtcg accatg                                                     16</s400><s200><s210>54</s210><s211>20</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>3&#x2032; tbs-MCS-Kozak variant</s223></s220></s200><s400> 54gagctcgaat tcgaaccatg                                                 20</s400><s200><s210>55</s210><s211>21</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>3&#x2032; tbs-MCS-Kozak variant</s223></s220></s200><s400> 55gagctctaga cgtcgaccat g                                               21</s400><s200><s210>56</s210><s211>22</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>3&#x2032; tbs-MCS-Kozak variant</s223></s220></s200><s400> 56gagctctaga attcgaacca tg                                              22</s400><s200><s210>57</s210><s211>23</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>3&#x2032; tbs-MCS-Kozak variant</s223></s220></s200><s400> 57gagctctaga tatcgatacc atg                                             23</s400><s200><s210>58</s210><s211>25</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>3&#x2032; tbs-MCS-Kozak variant</s223></s220></s200><s400> 58kagactagta cttaagctta ccatg                                           25</s400><s200><s210>59</s210><s211>32</s211><s212>DNA</s212><s213>Encephalomyocarditis virus</s213></s200><s400> 59cgtggttttc ctttgaaaaa cacgatgata cc                                   32</s400><s200><s210>60</s210><s211>56</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>optimal (overlapping) tbs-Kozak</s223></s220></s200><s400> 60gagtttagcg gagtggagaa gagcggagcc gagcctagca gagacgagcc gagatg         56</s400><s200><s210>61</s210><s211>65</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>optimal (overlapping) tbs-MCS-Kozak</s223></s220></s200><s400> 61gagtttagcg gagtggagaa gagcggagcc gagcctagca gagacgagaa gagctctaga     60ccatg                                                                 65</s400><s200><s210>62</s210><s211>74</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>illustrative nucleic acid sequence 1 containing      L33 Improved leader, optimal (overlapping) tbs ([KAGNN]8)-Kozak      junction</s223></s220></s200><s400> 62ctttttcgca acgggtttgc cgccagaaca caggagttta gcggagtgga gaagagcgga     60gccgagccga gatg                                                       74</s400><s200><s210>63</s210><s211>89</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>illustrative nucleic acid sequence 2 containing      L33 Improved leader, optimal (overlapping) tbs ([KAGNN]11)-Kozak      junction</s223></s220></s200><s400> 63ctttttcgca acgggtttgc cgccagaaca caggagttta gcggagtgga gaagagcgga     60gccgagccta gcagagacga gccgagatg                                       89</s400><s200><s210>64</s210><s211>68</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>illustrative nucleic acid sequence 3 containing      L12 Improved leader, optimal (overlapping) tbs ([KAGNN]11)-Kozak      junction</s223></s220></s200><s400> 64ctttttcgca acgagtttag cggagtggag aagagcggag ccgagcctag cagagacgag     60ccgagatg                                                              68</s400><s200><s210>65</s210><s211>101</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>illustrative nucleic acid sequence 4 for      intron-containing 5&#x2032;UTRs, resulting in a spliced leader comprising      L33, optimal (overlapping) tbs ([KAGNN]11)-Kozak junction</s223></s220></s200><s400> 65ctttttcgca acgggtttgc cgccagaaca caggtgtcgt gaaaagagtt tagcggagtg     60gagaagagcg gagccgagcc tagcagagac gagccgagat g                        101</s400><s200><s210>66</s210><s211>56</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>illustrative nucleic acid sequence 5 containing      improved spacer, optimal (overlapping) tbs ([KAGNN]8)-Kozak      junction</s223></s220></s200><s400> 66atagcagaga cggctgagtt tagcggagtg gagaagagcg gagccgagcc gagatg         56</s400><s200><s210>67</s210><s211>98</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>illustrative nucleic acid sequence 6 containing      L33 Improved leader tbs ([KAGNN]11)-MCS-Kozak</s223></s220></s200><s400> 67ctttttcgca acgggtttgc cgccagaaca caggagttta gcggagtgga gaagagcgga     60gccgagccta gcagagacga gaagagctct agaccatg                             98</s400><s200><s210>68</s210><s211>80</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>illustrative nucleic acid sequence 7 containing      improved spacer, tbs ([KAGNN]11)-MCS-Kozak</s223></s220></s200><s400> 68atagcagaga cggctgagtt tagcggagtg gagaagagcg gagccgagcc tagcagagac     60gagaagagct ctagaccatg                                                 80</s400><s200><s210>69</s210><s211>7</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>3&#x2032; tbs-Kozak junction variant</s223></s220></s200><s400> 69gagaatg                                                                7</s400><s200><s210>70</s210><s211>7</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>3&#x2032; tbs-Kozak junction variant</s223></s220></s200><s400> 70gagcatg                                                                7</s400><s200><s210>71</s210><s211>7</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>3&#x2032; tbs-Kozak junction variant</s223></s220></s200><s400> 71gaggatg                                                                7</s400><s200><s210>72</s210><s211>7</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>3&#x2032; tbs-Kozak junction variant</s223></s220></s200><s400> 72tagaatg                                                                7</s400><s200><s210>73</s210><s211>7</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>3&#x2032; tbs-Kozak junction variant</s223></s220></s200><s400> 73tagcatg                                                                7</s400><s200><s210>74</s210><s211>7</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>3&#x2032; tbs-Kozak junction variant</s223></s220></s200><s400> 74taggatg                                                                7</s400><s200><s210>75</s210><s211>8</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>3&#x2032; tbs-Kozak junction variant</s223></s220></s200><s400> 75gagaaatg                                                               8</s400><s200><s210>76</s210><s211>8</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>3&#x2032; tbs-Kozak junction variant</s223></s220></s200><s400> 76gagacatg                                                               8</s400><s200><s210>77</s210><s211>8</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>3&#x2032; tbs-Kozak junction variant</s223></s220></s200><s400> 77gagagatg                                                               8</s400><s200><s210>78</s210><s211>8</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>3&#x2032; tbs-Kozak junction variant</s223></s220></s200><s400> 78gagcaatg                                                               8</s400><s200><s210>79</s210><s211>8</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>3&#x2032; tbs-Kozak junction variant</s223></s220></s200><s400> 79gagccatg                                                               8</s400><s200><s210>80</s210><s211>8</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>3&#x2032; tbs-Kozak junction variant</s223></s220></s200><s400> 80gagcgatg                                                               8</s400><s200><s210>81</s210><s211>8</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>3&#x2032; tbs-Kozak junction variant</s223></s220></s200><s400> 81gaggaatg                                                               8</s400><s200><s210>82</s210><s211>8</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>3&#x2032; tbs-Kozak junction variant</s223></s220></s200><s400> 82gaggcatg                                                               8</s400><s200><s210>83</s210><s211>8</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>3&#x2032; tbs-Kozak junction variant</s223></s220></s200><s400> 83gagggatg                                                               8</s400><s200><s210>84</s210><s211>8</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>3&#x2032; tbs-Kozak junction variant</s223></s220></s200><s400> 84tagaaatg                                                               8</s400><s200><s210>85</s210><s211>8</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>3&#x2032; tbs-Kozak junction variant</s223></s220></s200><s400> 85tagacatg                                                               8</s400><s200><s210>86</s210><s211>8</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>3&#x2032; tbs-Kozak junction variant</s223></s220></s200><s400> 86tagagatg                                                               8</s400><s200><s210>87</s210><s211>8</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>3&#x2032; tbs-Kozak junction variant</s223></s220></s200><s400> 87tagcaatg                                                               8</s400><s200><s210>88</s210><s211>8</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>3&#x2032; tbs-Kozak junction variant</s223></s220></s200><s400> 88tagccatg                                                               8</s400><s200><s210>89</s210><s211>8</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>3&#x2032; tbs-Kozak junction variant</s223></s220></s200><s400> 89tagcgatg                                                               8</s400><s200><s210>90</s210><s211>8</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>3&#x2032; tbs-Kozak junction variant</s223></s220></s200><s400> 90taggaatg                                                               8</s400><s200><s210>91</s210><s211>8</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>3&#x2032; tbs-Kozak junction variant</s223></s220></s200><s400> 91taggcatg                                                               8</s400><s200><s210>92</s210><s211>8</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>3&#x2032; tbs-Kozak junction variant</s223></s220></s200><s400> 92tagggatg                                                               8</s400><s200><s210>93</s210><s211>45</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>L33 improved leader derived from a splicing      event</s223></s220></s200><s400> 93ctttttcgca acgggtttgc cgccagaaca caggtgtcgt gaaaa                     45</s400><s200><s210>94</s210><s211>30</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>splice donor region variant</s223></s220></s200><s400> 94ggggcggcga ctggtgagta cgccaaaaat                                      30</s400><s200><s210>95</s210><s211>30</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>splice donor region variant</s223></s220></s200><s400> 95ggggcggcga ctgcagacaa cgccaaaaat                                      30</s400><s200><s210>96</s210><s211>8</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>major splice donor consensus sequence variant</s223></s220></s200><s400> 96tggtragt                                                               8</s400><s200><s210>97</s210><s211>5</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>major splice donor consensus sequence variant</s223></s220></s200><s400> 97ctggt                                                                  5</s400><s200><s210>98</s210><s211>6</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>mutated splice donor region variant (MSD-2KO)</s223></s220></s200><s400> 98cagaca                                                                 6</s400><s200><s210>99</s210><s211>19</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>mutated splice donor region variant (MSD-2KO)</s223></s220></s200><s400> 99ggcgactgca gacaacgcc                                                  19</s400><s200><s210>100</s210><s211>9</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>mutated splice donor region variant (MSD-2KOv2)</s223></s220></s200><s400> 100gtggagact                                                              9</s400><s200><s210>101</s210><s211>19</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>mutated splice donor region variant (MSD-2KOv2)</s223></s220></s200><s400> 101ggcgagtgga gactacgcc                                                  19</s400><s200><s210>102</s210><s211>19</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>splice donor region SL2</s223></s220></s200><s400> 102ggcgactggt gagtacgcc                                                  19</s400><s200><s210>103</s210><s211>5</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>cryptic splice donor consensus sequence variant</s223></s220></s200><s400> 103tgagt                                                                  5</s400><s200><s210>104</s210><s211>30</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>mutated splice donor (MSD) region, MSD-2KOv2</s223></s220></s200><s400> 104ggggcggcga gtggagacta cgccaaaaat                                      30</s400><s200><s210>105</s210><s211>32</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>mutated splice donor (MSD) region, MSD-2KOm5</s223></s220></s200><s400> 105ggggaaggca acagataaat atgccttaaa at                                   32</s400><s200><s210>106</s210><s211>7</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>core sequence</s223></s220></s200><s400> 106gtgagta                                                                7</s400><s200><s210>107</s210><s211>23</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>mutated splice donor</s223></s220></s200><s400> 107aaggcaacag ataaatatgc ctt                                             23</s400><s200><s210>108</s210><s211>6</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>3&#x2032; tbs-Kozak junction variant</s223></s220></s200><s400> 108tagatg                                                                 6</s400><s200><s210>109</s210><s211>8</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>3&#x2032; tbs-Kozak junction variant</s223></s220></s200><s400> 109gagatatg                                                               8</s400><s200><s210>110</s210><s211>8</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>3&#x2032; tbs-Kozak junction variant</s223></s220></s200><s400> 110gagctatg                                                               8</s400><s200><s210>111</s210><s211>8</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>3&#x2032; tbs-Kozak junction variant</s223></s220></s200><s400> 111tagatatg                                                               8</s400><s200><s210>112</s210><s211>8</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>3&#x2032; tbs-Kozak junction variant</s223></s220></s200><s400> 112tagctatg                                                               8</s400><s200><s210>113</s210><s211>6</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>3&#x2032; tbs-Kozak junction variant</s223></s220><s220><s221>misc_feature</s221><s222>(4)..(5)</s222><s223>n is a, c, g, or t</s223></s220></s200><s400> 113kagnng                                                                 6</s400><s200><s210>114</s210><s211>6</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>3&#x2032; tbs-Kozak junction variant</s223></s220></s200><s400> 114kagatg                                                                 6</s400><s200><s210>115</s210><s211>7</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>3&#x2032; tbs-Kozak consensus sequence</s223></s220><s220><s221>misc_feature</s221><s222>(4)..(5)</s222><s223>n is a, c, g, or t</s223></s220></s200><s400> 115kagnntg                                                                7</s400><s200><s210>116</s210><s211>7</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>3&#x2032; tbs-Kozak consensus sequence</s223></s220><s220><s221>misc_feature</s221><s222>(4)..(4)</s222><s223>n is a, c, g, or t</s223></s220></s200><s400> 116kagnatg                                                                7</s400><s200><s210>117</s210><s211>1082</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>Chicken beta-Actin / Rabbit beta-globin      chimeric 5&#x2032;UTR-intron with tbs-kzkV0.G variant</s223></s220></s200><s400> 117cggcgggcgg gaacgttgcc ttcgccccgt gccccgctcc gcgccgcctc gcgccgcccg     60ccccggctct gactgaccgc gttactccca caggtgagcg ggcgggacgg cccttctccc    120tccgggctgt aattagcgct tggtttaatg acggctcgtt tcttttctgt ggctgcgtga    180aagccttaaa gggctccggg agggcctttg tgcggggggg agcggctcgg ggggtgcgtg    240cgtgtgtgtg tgcgtgggga gcgccgcgtg cggcccgcgc tgcccggcgg ctgtgagcgc    300tgcgggcgcg gcgcggggct ttgtgcgctc cgcgtgtgcg cgaggggagc gcgggccggg    360ggcggtgccc cgcggtgcgg gggggctgcg aggggaacaa aggctgcgtg cggggtgtgt    420gcgtgggggg gtgagcaggg ggtgtgggcg cggcggtcgg gctgtaaccc ccccctggca    480cccccctccc cgagttgctg agcacggccc ggcttcgggt gcggggctcc gtgcggggcg    540tggcgcgggg ctcgccgtgc cgggcggggg gtggcggcag gtgggggtgc cgggcggggc    600ggggccgcct cgggccgggg agggctcggg ggaggggcgc ggcggccccg gagcgccggc    660ggctgtcgag gcgcggcgag ccgcagccat tgccttttat ggtaatcgtg cgagagggcg    720cagggacttc ctttgtccca aatctggcgg agccgaaatc tgggaggcgc cgccgcaccc    780cctctagcgg gcgcgggcga agcggtgcgg cgccggcagg aaggaaatgg gcggggaggg    840ccttcgtgcg tcgccgcgcc gccgtcccct tctccatctc cagcctcggg gctgccgcag    900ggggacggct gccttcgggg gggacggggc agggcggggt tcggcttctg gcgtgtgacc    960ggcggcttta gagcctctgc taaccatgtt catgccttct tctttttcct acagctcctg   1020ggcaaagagt ttagcggagt ggagaagagc ggagccgagc ctagcagaga cgagccgaga   1080tg                                                                  1082</s400><s200><s210>118</s210><s211>1040</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>EF1a 5&#x2032;UTR-intron with tbskzkV0.G variant</s223></s220></s200><s400> 118ctttttcgca acgggtttgc cgccagaaca caggtaagtg ccgtgtgtgg ttcccgcggg     60cctggcctct ttacgggtta tggcccttgc gtgccttgaa ttacttccac ctggctgcag    120tacgtgattc ttgatcccga gcttcgggtt ggaagtgggt gggagagttc gtggccttgc    180gcttaaggag ccccttcgcc tcgtgcttga gttgtggcct ggcctgggcg ctggggccgc    240cgcgtgcgaa tctggtggca ccttcgcgcc tgtctcgctg ctttcgataa gtctctagcc    300atttaaaatt tttgatgacc tgctgcgacg ctttttttct ggcaagatag tcttgtaaat    360gcgggccaag atcagcacac tggtatttcg gtttttgggg ccgcgggcgg cgacggggcc    420cgtgcgtccc agcgcacatg ttcggcgagg cggggcctgc gagcgcggcc accgagaatc    480ggacgggggt agtctcaagc tgcccggcct gctctggtgc ctggcctcgc gccgccgtgt    540atcgccccgc cctgggcggc aaggctggcc cggtcggcac cagttgcgtg agcggaaaga    600tggccgcttc ccggccctgc tgcagggagc acaaaatgga ggacgcggcg ctcgggagag    660cgggcgggtg agtcacccac acaaaggaaa agggcctttc cgtcctcagc cgtcgcttca    720tgtgactcca cggagtaccg ggcgccgtcc aggcacctcg attagttctc cagcttttgg    780agtacgtcgt ctttaggttg gggggagggg ttttatgcga tggagtttcc ccacactgag    840tgggtggaga ctgaagttag gccagcttgg cacttgatgt aattctcctt ggaatttgcc    900ctttttgagt ttggatcttg gttcattctc aagcctcaga cagtggttca aagttttttt    960cttccatttc aggtgtcgtg aaaagagttt agcggagtgg agaagagcgg agccgagcct   1020agcagagacg agccgagatg                                               1040</s400><s200><s210>119</s210><s211>161</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>spliced sequence corresponding to SEQ ID NO      117</s223></s220></s200><s400> 119cggcgggcgg gaacgttgcc ttcgccccgt gccccgctcc gcgccgcctc gcgccgcccg     60ccccggctct gactgaccgc gttactccca cagctcctgg gcaaagagtt tagcggagtg    120gagaagagcg gagccgagcc tagcagagac gagccgagat g                        161</s400><s200><s210>120</s210><s211>101</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>spliced sequence corresponding to SEQ ID NO      118</s223></s220></s200><s400> 120ctttttcgca acgggtttgc cgccagaaca caggtgtcgt gaaaagagtt tagcggagtg     60gagaagagcg gagccgagcc tagcagagac gagccgagat g                        101</s400><s200><s210>121</s210><s211>1026</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>Chicken beta-Actin / Rabbit beta-globin      chimeric 5&#x2032;UTR-intron</s223></s220></s200><s400> 121cggcgggcgg gaacgttgcc ttcgccccgt gccccgctcc gcgccgcctc gcgccgcccg     60ccccggctct gactgaccgc gttactccca caggtgagcg ggcgggacgg cccttctccc    120tccgggctgt aattagcgct tggtttaatg acggctcgtt tcttttctgt ggctgcgtga    180aagccttaaa gggctccggg agggcctttg tgcggggggg agcggctcgg ggggtgcgtg    240cgtgtgtgtg tgcgtgggga gcgccgcgtg cggcccgcgc tgcccggcgg ctgtgagcgc    300tgcgggcgcg gcgcggggct ttgtgcgctc cgcgtgtgcg cgaggggagc gcgggccggg    360ggcggtgccc cgcggtgcgg gggggctgcg aggggaacaa aggctgcgtg cggggtgtgt    420gcgtgggggg gtgagcaggg ggtgtgggcg cggcggtcgg gctgtaaccc ccccctggca    480cccccctccc cgagttgctg agcacggccc ggcttcgggt gcggggctcc gtgcggggcg    540tggcgcgggg ctcgccgtgc cgggcggggg gtggcggcag gtgggggtgc cgggcggggc    600ggggccgcct cgggccgggg agggctcggg ggaggggcgc ggcggccccg gagcgccggc    660ggctgtcgag gcgcggcgag ccgcagccat tgccttttat ggtaatcgtg cgagagggcg    720cagggacttc ctttgtccca aatctggcgg agccgaaatc tgggaggcgc cgccgcaccc    780cctctagcgg gcgcgggcga agcggtgcgg cgccggcagg aaggaaatgg gcggggaggg    840ccttcgtgcg tcgccgcgcc gccgtcccct tctccatctc cagcctcggg gctgccgcag    900ggggacggct gccttcgggg gggacggggc agggcggggt tcggcttctg gcgtgtgacc    960ggcggcttta gagcctctgc taaccatgtt catgccttct tctttttcct acagctcctg   1020ggcaaa                                                              1026</s400><s200><s210>122</s210><s211>984</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>EF1a 5&#x2032;UTR-intron</s223></s220></s200><s400> 122ctttttcgca acgggtttgc cgccagaaca caggtaagtg ccgtgtgtgg ttcccgcggg     60cctggcctct ttacgggtta tggcccttgc gtgccttgaa ttacttccac ctggctgcag    120tacgtgattc ttgatcccga gcttcgggtt ggaagtgggt gggagagttc gtggccttgc    180gcttaaggag ccccttcgcc tcgtgcttga gttgtggcct ggcctgggcg ctggggccgc    240cgcgtgcgaa tctggtggca ccttcgcgcc tgtctcgctg ctttcgataa gtctctagcc    300atttaaaatt tttgatgacc tgctgcgacg ctttttttct ggcaagatag tcttgtaaat    360gcgggccaag atcagcacac tggtatttcg gtttttgggg ccgcgggcgg cgacggggcc    420cgtgcgtccc agcgcacatg ttcggcgagg cggggcctgc gagcgcggcc accgagaatc    480ggacgggggt agtctcaagc tgcccggcct gctctggtgc ctggcctcgc gccgccgtgt    540atcgccccgc cctgggcggc aaggctggcc cggtcggcac cagttgcgtg agcggaaaga    600tggccgcttc ccggccctgc tgcagggagc acaaaatgga ggacgcggcg ctcgggagag    660cgggcgggtg agtcacccac acaaaggaaa agggcctttc cgtcctcagc cgtcgcttca    720tgtgactcca cggagtaccg ggcgccgtcc aggcacctcg attagttctc cagcttttgg    780agtacgtcgt ctttaggttg gggggagggg ttttatgcga tggagtttcc ccacactgag    840tgggtggaga ctgaagttag gccagcttgg cacttgatgt aattctcctt ggaatttgcc    900ctttttgagt ttggatcttg gttcattctc aagcctcaga cagtggttca aagttttttt    960cttccatttc aggtgtcgtg aaaa                                           984</s400><s200><s210>123</s210><s211>1030</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>Chicken beta-Actin / Rabbit beta-globin      chimeric 5&#x2032;UTR-intron-tbs consensus</s223></s220><s220><s221>misc_feature</s221><s222>(1027)..(1030)</s222><s223>kagn(2-3) may be repeated 10-11 times</s223></s220><s220><s221>misc_feature</s221><s222>(1030)..(1030)</s222><s223>n may be repeated 2-3 times</s223></s220></s200><s400> 123cggcgggcgg gaacgttgcc ttcgccccgt gccccgctcc gcgccgcctc gcgccgcccg     60ccccggctct gactgaccgc gttactccca caggtgagcg ggcgggacgg cccttctccc    120tccgggctgt aattagcgct tggtttaatg acggctcgtt tcttttctgt ggctgcgtga    180aagccttaaa gggctccggg agggcctttg tgcggggggg agcggctcgg ggggtgcgtg    240cgtgtgtgtg tgcgtgggga gcgccgcgtg cggcccgcgc tgcccggcgg ctgtgagcgc    300tgcgggcgcg gcgcggggct ttgtgcgctc cgcgtgtgcg cgaggggagc gcgggccggg    360ggcggtgccc cgcggtgcgg gggggctgcg aggggaacaa aggctgcgtg cggggtgtgt    420gcgtgggggg gtgagcaggg ggtgtgggcg cggcggtcgg gctgtaaccc ccccctggca    480cccccctccc cgagttgctg agcacggccc ggcttcgggt gcggggctcc gtgcggggcg    540tggcgcgggg ctcgccgtgc cgggcggggg gtggcggcag gtgggggtgc cgggcggggc    600ggggccgcct cgggccgggg agggctcggg ggaggggcgc ggcggccccg gagcgccggc    660ggctgtcgag gcgcggcgag ccgcagccat tgccttttat ggtaatcgtg cgagagggcg    720cagggacttc ctttgtccca aatctggcgg agccgaaatc tgggaggcgc cgccgcaccc    780cctctagcgg gcgcgggcga agcggtgcgg cgccggcagg aaggaaatgg gcggggaggg    840ccttcgtgcg tcgccgcgcc gccgtcccct tctccatctc cagcctcggg gctgccgcag    900ggggacggct gccttcgggg gggacggggc agggcggggt tcggcttctg gcgtgtgacc    960ggcggcttta gagcctctgc taaccatgtt catgccttct tctttttcct acagctcctg   1020ggcaaakagn                                                          1030</s400><s200><s210>124</s210><s211>988</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>EF1a 5&#x2032;UTR-intron-tbs consensus</s223></s220><s220><s221>misc_feature</s221><s222>(985)..(988)</s222><s223>kagn(2-3) may be repeated 10-11 times</s223></s220><s220><s221>misc_feature</s221><s222>(988)..(988)</s222><s223>n may be repeated 2-3 times</s223></s220></s200><s400> 124ctttttcgca acgggtttgc cgccagaaca caggtaagtg ccgtgtgtgg ttcccgcggg     60cctggcctct ttacgggtta tggcccttgc gtgccttgaa ttacttccac ctggctgcag    120tacgtgattc ttgatcccga gcttcgggtt ggaagtgggt gggagagttc gtggccttgc    180gcttaaggag ccccttcgcc tcgtgcttga gttgtggcct ggcctgggcg ctggggccgc    240cgcgtgcgaa tctggtggca ccttcgcgcc tgtctcgctg ctttcgataa gtctctagcc    300atttaaaatt tttgatgacc tgctgcgacg ctttttttct ggcaagatag tcttgtaaat    360gcgggccaag atcagcacac tggtatttcg gtttttgggg ccgcgggcgg cgacggggcc    420cgtgcgtccc agcgcacatg ttcggcgagg cggggcctgc gagcgcggcc accgagaatc    480ggacgggggt agtctcaagc tgcccggcct gctctggtgc ctggcctcgc gccgccgtgt    540atcgccccgc cctgggcggc aaggctggcc cggtcggcac cagttgcgtg agcggaaaga    600tggccgcttc ccggccctgc tgcagggagc acaaaatgga ggacgcggcg ctcgggagag    660cgggcgggtg agtcacccac acaaaggaaa agggcctttc cgtcctcagc cgtcgcttca    720tgtgactcca cggagtaccg ggcgccgtcc aggcacctcg attagttctc cagcttttgg    780agtacgtcgt ctttaggttg gggggagggg ttttatgcga tggagtttcc ccacactgag    840tgggtggaga ctgaagttag gccagcttgg cacttgatgt aattctcctt ggaatttgcc    900ctttttgagt ttggatcttg gttcattctc aagcctcaga cagtggttca aagttttttt    960cttccatttc aggtgtcgtg aaaakagn                                       988</s400><s200><s210>125</s210><s211>6</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>Kozak sequence</s223></s220><s220><s221>misc_feature</s221><s222>(2)..(3)</s222><s223>n is a, c, g, t or u</s223></s220></s200><s400> 125rnnatg                                                                 6</s400><s200><s210>126</s210><s211>12</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>original tbs-Kozak region sequence</s223></s220></s200><s400> 126acagccacca tg                                                         12</s400><s200><s210>127</s210><s211>17</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>HpaI variant tbs-Kozak region sequence</s223></s220></s200><s400> 127gagttaacgc caccatg                                                    17</s400><s200><s210>128</s210><s211>13</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>full Kozak consensus sequence for DNA</s223></s220></s200><s400> 128gccgccrcca tgg                                                        13</s400><s200><s210>129</s210><s211>13</s211><s212>RNA</s212><s213>Artificial Sequence</s213><s220><s223>full Kozak consensus sequence for RNA</s223></s220></s200><s400> 129gccgccrcca ugg                                                        13</s400><s200><s210>130</s210><s211>10</s211><s212>RNA</s212><s213>Artificial Sequence</s213><s220><s223>extended Kozak consensus sequence</s223></s220><s220><s221>misc_feature</s221><s222>(2)..(3)</s222><s223>n is a, c, g, or u</s223></s220></s200><s400> 130gnnrvvaugg                                                            10</s400><s200><s210>131</s210><s211>153</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>main U1 snRNA sequence [clover leaf]      (nt 410-562) of the U1_256 sequence</s223></s220></s200><s400> 131gcaggggaga taccatgatc acgaaggtgg ttttcccagg gcgaggctta tccattgcac     60tccggatgtg ctgacccctg cgatttcccc aaatgtggga aactcgactg cataatttgt    120ggtagtgggg gactgcgttc gcgctttccc ctg                                 153</s400><s200><s210>132</s210><s211>34</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>UTR-leader sequence (CMV)</s223></s220></s200><s400> 132gtcagatccg ctagcgctac cggactcaga tctc                                 34</s400><s200><s210>133</s210><s211>92</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>UTR-leader sequence (RSV)</s223></s220></s200><s400> 133gccatttgac cattcaccac attggtgtgc acctccaagg ccaagatctt tgtcgatcct     60accatccact cgacacaccc gccagcggcc gc                                   92</s400><s200><s210>134</s210><s211>91</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>UTR-leader sequence (EF1a)</s223></s220></s200><s400> 134ctttttcgca acgggtttgc cgccagaaca caggtgtcgt gaaaactacc cctaaaagcc     60aaaagatctt tgtcgatcct accatccact c                                    91</s400><s200><s210>135</s210><s211>405</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>UTR-leader sequence (UBC)</s223></s220></s200><s400> 135agctagttcc gtcgcagccg ggatttgggt cgcggttctt gtttgtggat cgctgtgatc     60gtcacttgga cgcagggttc gggcctaggg taggctctcc tgaatcgaca ggcgccggac    120ctctggtgag gggagggata agtgaggcgt cagtttcttt ggtcggtttt atgtacctat    180cttcttaagt agctgaagct ccggttttga actatgcgct cggggttggc gagtgtgttt    240tgtgaagttt tttaggcacc ttttgaaatg taatcatttg ggtcaatatg taattttcag    300tgttagactt gtaaattgtc cgctaaattc tggccgtttt tggctttttt gttagacaac    360agatcttgat cctaccatcc actcgacaca cccgccagcg gccgc                    405</s400><s200><s210>136</s210><s211>104</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>UTR-leader sequence (SV40)</s223></s220></s200><s400> 136ctctgagcta ttccagaagt agtgaggagg cttttttgga ggcctaggct tttgcagatc     60tttgtcgatc ctaccatcca ctcgacacac ccgccagcgg ccgc                     104</s400><s200><s210>137</s210><s211>143</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>UTR-leader sequence (huPGK)</s223></s220></s200><s400> 137gttccgcatt ctggcaagcc tccggagcgc acgtcggcag tcggctccct cgttgaccga     60atcaccgacc tctctcccca gctgtatttc caaaagatct ttgtcgatcc taccatccac    120tcgacacacc cgccagcggc cgc                                            143</s400><s200><s210>138</s210><s211>79</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>UTR-leader sequence (hsvTK)</s223></s220></s200><s400> 138acaccgagcg accctgcagc gacccgctta agatctttgt cgatcctacc atccactcga     60cacacccgcc agcggccgc                                                  79</s400><s200><s210>139</s210><s211>33</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>UTR-leader sequence (Improved leader L33)</s223></s220></s200><s400> 139ctttttcgca acgggtttgc cgccagaaca cag                                  33</s400><s200><s210>140</s210><s211>12</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>UTR-leader sequence (Improved leader L12)</s223></s220></s200><s400> 140ctttttcgca ac                                                         12</s400><s200><s210>141</s210><s211>55</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>tbs sequence</s223></s220></s200><s400> 141gagtttagcg gagtggagaa gagcggagcc gagcctagca gagacgagtg gagct          55</s400><s200><s210>142</s210><s211>55</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>tbs consensus sequence</s223></s220><s220><s221>misc_feature</s221><s222>(4)..(5)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(9)..(10)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(14)..(15)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(19)..(20)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(24)..(25)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(29)..(30)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(34)..(35)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(39)..(40)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(44)..(45)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(49)..(50)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(54)..(55)</s222><s223>n is a, c, g, or t</s223></s220></s200><s400> 142kagnnkagnn kagnnkagnn kagnnkagnn kagnnkagnn kagnnkagnn kagnn          55</s400><s200><s210>143</s210><s211>12</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>multiple cloning site (MCS) sequence variant,      No MCS</s223></s220></s200><s400> 143acagccacca tg                                                         12</s400><s200><s210>144</s210><s211>15</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>MCS sequence variant, MCS2.1</s223></s220></s200><s400> 144gagctctaga ccatg                                                      15</s400><s200><s210>145</s210><s211>16</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>MCS sequence variant, MCS3.1</s223></s220></s200><s400> 145gagctcgtcg accatg                                                     16</s400><s200><s210>146</s210><s211>20</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>MCS sequence variant, MCS3.2</s223></s220></s200><s400> 146gagctcgaat tcgaaccatg                                                 20</s400><s200><s210>147</s210><s211>21</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>MCS sequence variant, MCS4.1</s223></s220></s200><s400> 147gagctctaga cgtcgaccat g                                               21</s400><s200><s210>148</s210><s211>22</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>MCS sequence variant, MCS4.2</s223></s220></s200><s400> 148gagctctaga attcgaacca tg                                              22</s400><s200><s210>149</s210><s211>23</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>MCS sequence variant, MCS4.3</s223></s220></s200><s400> 149gagctctaga tatcgatacc atg                                             23</s400><s200><s210>150</s210><s211>25</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>MCS sequence variant, MCS4.4</s223></s220></s200><s400> 150kagactagta cttaagctta ccatg                                           25</s400><s200><s210>151</s210><s211>17</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>3&#x2032;tbs-Kozak junction sequence, original</s223></s220><s220><s221>misc_feature</s221><s222>(4)..(5)</s222><s223>n is a, c, g, or t</s223></s220></s200><s400> 151kagnnacagc caccatg                                                    17</s400><s200><s210>152</s210><s211>11</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>3&#x2032;tbs-Kozak junction sequence, variant &#x2032;0&#x2032;</s223></s220></s200><s400> 152kagccgagat g                                                          11</s400><s200><s210>153</s210><s211>12</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>3&#x2032;tbs-Kozak junction sequence, variant &#x2032;1&#x2032;</s223></s220></s200><s400> 153kaggcgagca tg                                                         12</s400><s200><s210>154</s210><s211>13</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>3&#x2032;tbs-Kozak junction sequence, variant &#x2032;2&#x2032;</s223></s220><s220><s221>misc_feature</s221><s222>(4)..(4)</s222><s223>n is a, c, g, or t</s223></s220></s200><s400> 154kagnggagcc atg                                                        13</s400><s200><s210>155</s210><s211>14</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>3&#x2032;tbs-Kozak junction sequence, variant &#x2032;3&#x2032;</s223></s220><s220><s221>misc_feature</s221><s222>(4)..(5)</s222><s223>n is a, c, g, or t</s223></s220></s200><s400> 155kagnngagac catg                                                       14</s400><s200><s210>156</s210><s211>105</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>IRES-spacer-Kozak variant sequence, Original      [26nt]</s223></s220><s220><s221>misc_feature</s221><s222>(59)..(63)</s222><s223>kagnn may be repeated 7-11 times</s223></s220><s220><s221>misc_feature</s221><s222>(67)..(68)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(72)..(73)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(77)..(78)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(82)..(83)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(87)..(88)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(92)..(93)</s222><s223>n is a, c, g, or t</s223></s220></s200><s400> 156cgtggttttc ctttgaaaaa cacgatgata ccatagcaga gacggctagc gttaacctka     60gnnkagnnka gnnkagnnka gnnkagnnka gnnaacgcca ccatg                    105</s400><s200><s210>157</s210><s211>94</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>IRES-spacer-Kozak variant sequence, Original      [Trunc-15nt]</s223></s220><s220><s221>misc_feature</s221><s222>(48)..(52)</s222><s223>kagnn may be repeated 7-11 times</s223></s220><s220><s221>misc_feature</s221><s222>(56)..(57)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(61)..(62)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(66)..(67)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(71)..(72)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(76)..(77)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(81)..(82)</s222><s223>n is a, c, g, or t</s223></s220></s200><s400> 157cgtggttttc ctttgaaaaa cacgatgata ccatagcaga gacggctkag nnkagnnkag     60nnkagnnkag nnkagnnkag nnaacgccac catg                                 94</s400><s200><s210>158</s210><s211>89</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>IRES-spacer-Kozak variant sequence, Original      [Trunc-10nt]</s223></s220><s220><s221>misc_feature</s221><s222>(43)..(47)</s222><s223>kagnn may be repeated 7-11 times</s223></s220><s220><s221>misc_feature</s221><s222>(51)..(52)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(56)..(57)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(61)..(62)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(66)..(67)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(71)..(72)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(76)..(77)</s222><s223>n is a, c, g, or t</s223></s220></s200><s400> 158cgtggttttc ctttgaaaaa cacgatgata ccatagcaga gakagnnkag nnkagnnkag     60nnkagnnkag nnkagnnaac gccaccatg                                       89</s400><s200><s210>159</s210><s211>84</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>IRES-spacer-Kozak variant sequence, Original      [Trunc-5nt]</s223></s220><s220><s221>misc_feature</s221><s222>(38)..(42)</s222><s223>kagnn may be repeated 7-11 times</s223></s220><s220><s221>misc_feature</s221><s222>(46)..(47)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(51)..(52)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(56)..(57)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(61)..(62)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(66)..(67)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(71)..(72)</s222><s223>n is a, c, g, or t</s223></s220></s200><s400> 159cgtggttttc ctttgaaaaa cacgatgata ccatagckag nnkagnnkag nnkagnnkag     60nnkagnnkag nnaacgccac catg                                            84</s400><s200><s210>160</s210><s211>79</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>IRES-spacer-Kozak variant sequence, No Spacer      [0nt]</s223></s220><s220><s221>misc_feature</s221><s222>(33)..(37)</s222><s223>kagnn may be repeated 7-11 times</s223></s220><s220><s221>misc_feature</s221><s222>(41)..(42)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(46)..(47)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(51)..(52)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(56)..(57)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(61)..(62)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(66)..(67)</s222><s223>n is a, c, g, or t</s223></s220></s200><s400> 160cgtggttttc ctttgaaaaa cacgatgata cckagnnkag nnkagnnkag nnkagnnkag     60nnkagnnaac gccaccatg                                                  79</s400><s200><s210>161</s210><s211>105</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>IRES-spacer-Kozak variant sequence, Variant      [26nt]</s223></s220><s220><s221>misc_feature</s221><s222>(59)..(63)</s222><s223>kagnn may be repeated 7-11 times</s223></s220><s220><s221>misc_feature</s221><s222>(67)..(68)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(72)..(73)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(77)..(78)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(82)..(83)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(87)..(88)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(92)..(93)</s222><s223>n is a, c, g, or t</s223></s220></s200><s400> 161cgtggttttc ctttgaaaaa cacgatgata ccatatcaga gacggctagc gtataccaka     60gnnkagnnka gnnkagnnka gnnkagnnka gnnaacgcca ccatg                    105</s400><s200><s210>162</s210><s211>94</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>IRES-spacer-Kozak variant sequence, Variant      [Trunc-15nt]</s223></s220><s220><s221>misc_feature</s221><s222>(48)..(52)</s222><s223>kagnn may be repeated 7-11 times</s223></s220><s220><s221>misc_feature</s221><s222>(56)..(57)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(61)..(62)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(66)..(67)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(71)..(72)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(76)..(77)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(81)..(82)</s222><s223>n is a, c, g, or t</s223></s220></s200><s400> 162cgtggttttc ctttgaaaaa cacgatgata ccatatcaga gacggctkag nnkagnnkag     60nnkagnnkag nnkagnnkag nnaacgccac catg                                 94</s400><s200><s210>163</s210><s211>89</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>IRES-spacer-Kozak variant sequence, Variant      [Trunc-10nt]</s223></s220><s220><s221>misc_feature</s221><s222>(43)..(47)</s222><s223>kagnn may be repeated 7-11 times</s223></s220><s220><s221>misc_feature</s221><s222>(51)..(52)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(56)..(57)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(61)..(62)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(66)..(67)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(71)..(72)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(76)..(77)</s222><s223>n is a, c, g, or t</s223></s220></s200><s400> 163cgtggttttc ctttgaaaaa cacgatgata ccagagacgg ctkagnnkag nnkagnnkag     60nnkagnnkag nnkagnnaac gccaccatg                                       89</s400><s200><s210>164</s210><s211>84</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>IRES-spacer-Kozak variant sequence, Variant      [Trunc-5nt]</s223></s220><s220><s221>misc_feature</s221><s222>(38)..(42)</s222><s223>kagnn may be repeated 7-11 times</s223></s220><s220><s221>misc_feature</s221><s222>(46)..(47)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(51)..(52)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(56)..(57)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(61)..(62)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(66)..(67)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(71)..(72)</s222><s223>n is a, c, g, or t</s223></s220></s200><s400> 164cgtggttttc ctttgaaaaa cacgatgata cctaccakag nnkagnnkag nnkagnnkag     60nnkagnnkag nnaacgccac catg                                            84</s400><s200><s210>165</s210><s211>86</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>IRES-spacer-Kozak variant sequence, Original      [Trunc-15nt]-3ntKozak</s223></s220><s220><s221>misc_feature</s221><s222>(48)..(52)</s222><s223>kagnn may be repeated 6-10 times</s223></s220><s220><s221>misc_feature</s221><s222>(56)..(57)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(61)..(62)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(66)..(67)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(71)..(72)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(76)..(77)</s222><s223>n is a, c, g, or t</s223></s220></s200><s400> 165cgtggttttc ctttgaaaaa cacgatgata ccatagcaga gacggctkag nnkagnnkag     60nnkagnnkag nnkagnngag accatg                                          86</s400><s200><s210>166</s210><s211>94</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>IRES-spacer-Kozak variant sequence, Original      [Trunc-15nt]-9ntKozak</s223></s220><s220><s221>misc_feature</s221><s222>(48)..(52)</s222><s223>kagnn may be repeated 7-11 times</s223></s220><s220><s221>misc_feature</s221><s222>(56)..(57)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(61)..(62)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(66)..(67)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(71)..(72)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(76)..(77)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(81)..(82)</s222><s223>n is a, c, g, or t</s223></s220></s200><s400> 166cgtggttttc ctttgaaaaa cacgatgata ccatagcaga gacggctkag nnkagnnkag     60nnkagnnkag nnkagnnkag nnaacgccac catg                                 94</s400><s200><s210>167</s210><s211>67</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>overlapping tbs 3&#x2032;KAGNN-Kozak variant</s223></s220><s220><s221>misc_feature</s221><s222>(4)..(5)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(9)..(10)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(14)..(15)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(19)..(20)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(24)..(25)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(29)..(30)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(34)..(35)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(39)..(40)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(44)..(45)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(49)..(50)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(54)..(55)</s222><s223>n is a, c, g, or t</s223></s220></s200><s400> 167kagnnkagnn kagnnkagnn kagnnkagnn kagnnkagnn kagnnkagnn kagnnacagc     60caccatg                                                               67</s400><s200><s210>168</s210><s211>56</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>overlapping tbs 3&#x2032;KAGNN-Kozak variant</s223></s220><s220><s221>misc_feature</s221><s222>(4)..(5)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(9)..(10)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(14)..(15)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(19)..(20)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(24)..(25)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(29)..(30)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(34)..(35)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(39)..(40)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(44)..(45)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(49)..(50)</s222><s223>n is a, c, g, or t</s223></s220></s200><s400> 168kagnnkagnn kagnnkagnn kagnnkagnn kagnnkagnn kagnnkagnn gagatg         56</s400><s200><s210>169</s210><s211>56</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>overlapping tbs 3&#x2032;KAGNN-Kozak variant</s223></s220><s220><s221>misc_feature</s221><s222>(4)..(5)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(9)..(10)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(14)..(15)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(19)..(20)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(24)..(25)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(29)..(30)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(34)..(35)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(39)..(40)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(44)..(45)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(49)..(50)</s222><s223>n is a, c, g, or t</s223></s220></s200><s400> 169kagnnkagnn kagnnkagnn kagnnkagnn kagnnkagnn kagnnkagnn tagatg         56</s400><s200><s210>170</s210><s211>57</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>overlapping tbs 3&#x2032;KAGNN-Kozak variant</s223></s220><s220><s221>misc_feature</s221><s222>(4)..(5)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(9)..(10)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(14)..(15)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(19)..(20)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(24)..(25)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(29)..(30)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(34)..(35)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(39)..(40)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(44)..(45)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(49)..(50)</s222><s223>n is a, c, g, or t</s223></s220></s200><s400> 170kagnnkagnn kagnnkagnn kagnnkagnn kagnnkagnn kagnnkagnn gagcatg        57</s400><s200><s210>171</s210><s211>57</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>overlapping tbs 3&#x2032;KAGNN-Kozak variant</s223></s220><s220><s221>misc_feature</s221><s222>(4)..(5)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(9)..(10)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(14)..(15)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(19)..(20)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(24)..(25)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(29)..(30)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(34)..(35)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(39)..(40)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(44)..(45)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(49)..(50)</s222><s223>n is a, c, g, or t</s223></s220></s200><s400> 171kagnnkagnn kagnnkagnn kagnnkagnn kagnnkagnn kagnnkagnn gagaatg        57</s400><s200><s210>172</s210><s211>57</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>overlapping tbs 3&#x2032;KAGNN-Kozak variant</s223></s220><s220><s221>misc_feature</s221><s222>(4)..(5)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(9)..(10)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(14)..(15)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(19)..(20)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(24)..(25)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(29)..(30)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(34)..(35)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(39)..(40)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(44)..(45)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(49)..(50)</s222><s223>n is a, c, g, or t</s223></s220></s200><s400> 172kagnnkagnn kagnnkagnn kagnnkagnn kagnnkagnn kagnnkagnn gaggatg        57</s400><s200><s210>173</s210><s211>57</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>overlapping tbs 3&#x2032;KAGNN-Kozak variant</s223></s220><s220><s221>misc_feature</s221><s222>(4)..(5)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(9)..(10)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(14)..(15)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(19)..(20)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(24)..(25)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(29)..(30)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(34)..(35)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(39)..(40)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(44)..(45)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(49)..(50)</s222><s223>n is a, c, g, or t</s223></s220></s200><s400> 173kagnnkagnn kagnnkagnn kagnnkagnn kagnnkagnn kagnnkagnn tagaatg        57</s400><s200><s210>174</s210><s211>57</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>overlapping tbs 3&#x2032;KAGNN-Kozak variant</s223></s220><s220><s221>misc_feature</s221><s222>(4)..(5)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(9)..(10)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(14)..(15)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(19)..(20)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(24)..(25)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(29)..(30)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(34)..(35)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(39)..(40)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(44)..(45)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(49)..(50)</s222><s223>n is a, c, g, or t</s223></s220></s200><s400> 174kagnnkagnn kagnnkagnn kagnnkagnn kagnnkagnn kagnnkagnn tagcatg        57</s400><s200><s210>175</s210><s211>57</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>overlapping tbs 3&#x2032;KAGNN-Kozak variant</s223></s220><s220><s221>misc_feature</s221><s222>(4)..(5)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(9)..(10)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(14)..(15)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(19)..(20)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(24)..(25)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(29)..(30)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(34)..(35)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(39)..(40)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(44)..(45)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(49)..(50)</s222><s223>n is a, c, g, or t</s223></s220></s200><s400> 175kagnnkagnn kagnnkagnn kagnnkagnn kagnnkagnn kagnnkagnn taggatg        57</s400><s200><s210>176</s210><s211>58</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>overlapping tbs 3&#x2032;KAGNN-Kozak variant</s223></s220><s220><s221>misc_feature</s221><s222>(4)..(5)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(9)..(10)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(14)..(15)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(19)..(20)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(24)..(25)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(29)..(30)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(34)..(35)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(39)..(40)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(44)..(45)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(49)..(50)</s222><s223>n is a, c, g, or t</s223></s220></s200><s400> 176kagnnkagnn kagnnkagnn kagnnkagnn kagnnkagnn kagnnkagnn gagccatg       58</s400><s200><s210>177</s210><s211>58</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>overlapping tbs 3&#x2032;KAGNN-Kozak variant</s223></s220><s220><s221>misc_feature</s221><s222>(4)..(5)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(9)..(10)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(14)..(15)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(19)..(20)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(24)..(25)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(29)..(30)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(34)..(35)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(39)..(40)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(44)..(45)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(49)..(50)</s222><s223>n is a, c, g, or t</s223></s220></s200><s400> 177kagnnkagnn kagnnkagnn kagnnkagnn kagnnkagnn kagnnkagnn gagaaatg       58</s400><s200><s210>178</s210><s211>58</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>overlapping tbs 3&#x2032;KAGNN-Kozak variant</s223></s220><s220><s221>misc_feature</s221><s222>(4)..(5)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(9)..(10)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(14)..(15)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(19)..(20)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(24)..(25)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(29)..(30)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(34)..(35)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(39)..(40)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(44)..(45)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(49)..(50)</s222><s223>n is a, c, g, or t</s223></s220></s200><s400> 178kagnnkagnn kagnnkagnn kagnnkagnn kagnnkagnn kagnnkagnn gagagatg       58</s400><s200><s210>179</s210><s211>58</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>overlapping tbs 3&#x2032;KAGNN-Kozak variant</s223></s220><s220><s221>misc_feature</s221><s222>(4)..(5)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(9)..(10)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(14)..(15)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(19)..(20)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(24)..(25)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(29)..(30)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(34)..(35)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(39)..(40)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(44)..(45)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(49)..(50)</s222><s223>n is a, c, g, or t</s223></s220></s200><s400> 179kagnnkagnn kagnnkagnn kagnnkagnn kagnnkagnn kagnnkagnn gagacatg       58</s400><s200><s210>180</s210><s211>58</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>overlapping tbs 3&#x2032;KAGNN-Kozak variant</s223></s220><s220><s221>misc_feature</s221><s222>(4)..(5)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(9)..(10)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(14)..(15)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(19)..(20)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(24)..(25)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(29)..(30)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(34)..(35)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(39)..(40)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(44)..(45)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(49)..(50)</s222><s223>n is a, c, g, or t</s223></s220></s200><s400> 180kagnnkagnn kagnnkagnn kagnnkagnn kagnnkagnn kagnnkagnn gagatatg       58</s400><s200><s210>181</s210><s211>58</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>overlapping tbs 3&#x2032;KAGNN-Kozak variant</s223></s220><s220><s221>misc_feature</s221><s222>(4)..(5)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(9)..(10)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(14)..(15)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(19)..(20)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(24)..(25)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(29)..(30)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(34)..(35)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(39)..(40)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(44)..(45)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(49)..(50)</s222><s223>n is a, c, g, or t</s223></s220></s200><s400> 181kagnnkagnn kagnnkagnn kagnnkagnn kagnnkagnn kagnnkagnn gagcaatg       58</s400><s200><s210>182</s210><s211>58</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>overlapping tbs 3&#x2032;KAGNN-Kozak variant</s223></s220><s220><s221>misc_feature</s221><s222>(4)..(5)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(9)..(10)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(14)..(15)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(19)..(20)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(24)..(25)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(29)..(30)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(34)..(35)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(39)..(40)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(44)..(45)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(49)..(50)</s222><s223>n is a, c, g, or t</s223></s220></s200><s400> 182kagnnkagnn kagnnkagnn kagnnkagnn kagnnkagnn kagnnkagnn gagcgatg       58</s400><s200><s210>183</s210><s211>58</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>overlapping tbs 3&#x2032;KAGNN-Kozak variant</s223></s220><s220><s221>misc_feature</s221><s222>(4)..(5)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(9)..(10)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(14)..(15)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(19)..(20)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(24)..(25)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(29)..(30)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(34)..(35)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(39)..(40)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(44)..(45)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(49)..(50)</s222><s223>n is a, c, g, or t</s223></s220></s200><s400> 183kagnnkagnn kagnnkagnn kagnnkagnn kagnnkagnn kagnnkagnn gagctatg       58</s400><s200><s210>184</s210><s211>58</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>overlapping tbs 3&#x2032;KAGNN-Kozak variant</s223></s220><s220><s221>misc_feature</s221><s222>(4)..(5)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(9)..(10)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(14)..(15)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(19)..(20)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(24)..(25)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(29)..(30)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(34)..(35)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(39)..(40)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(44)..(45)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(49)..(50)</s222><s223>n is a, c, g, or t</s223></s220></s200><s400> 184kagnnkagnn kagnnkagnn kagnnkagnn kagnnkagnn kagnnkagnn gaggaatg       58</s400><s200><s210>185</s210><s211>58</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>overlapping tbs 3&#x2032;KAGNN-Kozak variant</s223></s220><s220><s221>misc_feature</s221><s222>(4)..(5)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(9)..(10)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(14)..(15)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(19)..(20)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(24)..(25)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(29)..(30)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(34)..(35)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(39)..(40)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(44)..(45)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(49)..(50)</s222><s223>n is a, c, g, or t</s223></s220></s200><s400> 185kagnnkagnn kagnnkagnn kagnnkagnn kagnnkagnn kagnnkagnn gagggatg       58</s400><s200><s210>186</s210><s211>58</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>overlapping tbs 3&#x2032;KAGNN-Kozak variant</s223></s220><s220><s221>misc_feature</s221><s222>(4)..(5)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(9)..(10)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(14)..(15)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(19)..(20)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(24)..(25)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(29)..(30)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(34)..(35)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(39)..(40)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(44)..(45)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(49)..(50)</s222><s223>n is a, c, g, or t</s223></s220></s200><s400> 186kagnnkagnn kagnnkagnn kagnnkagnn kagnnkagnn kagnnkagnn gaggcatg       58</s400><s200><s210>187</s210><s211>58</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>overlapping tbs 3&#x2032;KAGNN-Kozak variant</s223></s220><s220><s221>misc_feature</s221><s222>(4)..(5)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(9)..(10)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(14)..(15)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(19)..(20)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(24)..(25)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(29)..(30)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(34)..(35)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(39)..(40)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(44)..(45)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(49)..(50)</s222><s223>n is a, c, g, or t</s223></s220></s200><s400> 187kagnnkagnn kagnnkagnn kagnnkagnn kagnnkagnn kagnnkagnn tagaaatg       58</s400><s200><s210>188</s210><s211>58</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>overlapping tbs 3&#x2032;KAGNN-Kozak variant</s223></s220><s220><s221>misc_feature</s221><s222>(4)..(5)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(9)..(10)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(14)..(15)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(19)..(20)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(24)..(25)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(29)..(30)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(34)..(35)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(39)..(40)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(44)..(45)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(49)..(50)</s222><s223>n is a, c, g, or t</s223></s220></s200><s400> 188kagnnkagnn kagnnkagnn kagnnkagnn kagnnkagnn kagnnkagnn tagagatg       58</s400><s200><s210>189</s210><s211>58</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>overlapping tbs 3&#x2032;KAGNN-Kozak variant</s223></s220><s220><s221>misc_feature</s221><s222>(4)..(5)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(9)..(10)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(14)..(15)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(19)..(20)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(24)..(25)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(29)..(30)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(34)..(35)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(39)..(40)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(44)..(45)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(49)..(50)</s222><s223>n is a, c, g, or t</s223></s220></s200><s400> 189kagnnkagnn kagnnkagnn kagnnkagnn kagnnkagnn kagnnkagnn tagacatg       58</s400><s200><s210>190</s210><s211>58</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>overlapping tbs 3&#x2032;KAGNN-Kozak variant</s223></s220><s220><s221>misc_feature</s221><s222>(4)..(5)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(9)..(10)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(14)..(15)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(19)..(20)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(24)..(25)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(29)..(30)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(34)..(35)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(39)..(40)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(44)..(45)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(49)..(50)</s222><s223>n is a, c, g, or t</s223></s220></s200><s400> 190kagnnkagnn kagnnkagnn kagnnkagnn kagnnkagnn kagnnkagnn tagatatg       58</s400><s200><s210>191</s210><s211>58</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>overlapping tbs 3&#x2032;KAGNN-Kozak variant</s223></s220><s220><s221>misc_feature</s221><s222>(4)..(5)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(9)..(10)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(14)..(15)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(19)..(20)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(24)..(25)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(29)..(30)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(34)..(35)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(39)..(40)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(44)..(45)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(49)..(50)</s222><s223>n is a, c, g, or t</s223></s220></s200><s400> 191kagnnkagnn kagnnkagnn kagnnkagnn kagnnkagnn kagnnkagnn tagcaatg       58</s400><s200><s210>192</s210><s211>58</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>overlapping tbs 3&#x2032;KAGNN-Kozak variant</s223></s220><s220><s221>misc_feature</s221><s222>(4)..(5)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(9)..(10)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(14)..(15)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(19)..(20)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(24)..(25)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(29)..(30)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(34)..(35)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(39)..(40)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(44)..(45)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(49)..(50)</s222><s223>n is a, c, g, or t</s223></s220></s200><s400> 192kagnnkagnn kagnnkagnn kagnnkagnn kagnnkagnn kagnnkagnn tagcgatg       58</s400><s200><s210>193</s210><s211>58</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>overlapping tbs 3&#x2032;KAGNN-Kozak variant</s223></s220><s220><s221>misc_feature</s221><s222>(4)..(5)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(9)..(10)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(14)..(15)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(19)..(20)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(24)..(25)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(29)..(30)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(34)..(35)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(39)..(40)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(44)..(45)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(49)..(50)</s222><s223>n is a, c, g, or t</s223></s220></s200><s400> 193kagnnkagnn kagnnkagnn kagnnkagnn kagnnkagnn kagnnkagnn tagccatg       58</s400><s200><s210>194</s210><s211>58</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>overlapping tbs 3&#x2032;KAGNN-Kozak variant</s223></s220><s220><s221>misc_feature</s221><s222>(4)..(5)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(9)..(10)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(14)..(15)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(19)..(20)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(24)..(25)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(29)..(30)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(34)..(35)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(39)..(40)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(44)..(45)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(49)..(50)</s222><s223>n is a, c, g, or t</s223></s220></s200><s400> 194kagnnkagnn kagnnkagnn kagnnkagnn kagnnkagnn kagnnkagnn tagctatg       58</s400><s200><s210>195</s210><s211>58</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>overlapping tbs 3&#x2032;KAGNN-Kozak variant</s223></s220><s220><s221>misc_feature</s221><s222>(4)..(5)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(9)..(10)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(14)..(15)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(19)..(20)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(24)..(25)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(29)..(30)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(34)..(35)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(39)..(40)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(44)..(45)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(49)..(50)</s222><s223>n is a, c, g, or t</s223></s220></s200><s400> 195kagnnkagnn kagnnkagnn kagnnkagnn kagnnkagnn kagnnkagnn taggaatg       58</s400><s200><s210>196</s210><s211>58</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>overlapping tbs 3&#x2032;KAGNN-Kozak variant</s223></s220><s220><s221>misc_feature</s221><s222>(4)..(5)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(9)..(10)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(14)..(15)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(19)..(20)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(24)..(25)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(29)..(30)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(34)..(35)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(39)..(40)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(44)..(45)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(49)..(50)</s222><s223>n is a, c, g, or t</s223></s220></s200><s400> 196kagnnkagnn kagnnkagnn kagnnkagnn kagnnkagnn kagnnkagnn tagggatg       58</s400><s200><s210>197</s210><s211>58</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>overlapping tbs 3&#x2032;KAGNN-Kozak variant</s223></s220><s220><s221>misc_feature</s221><s222>(4)..(5)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(9)..(10)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(14)..(15)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(19)..(20)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(24)..(25)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(29)..(30)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(34)..(35)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(39)..(40)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(44)..(45)</s222><s223>n is a, c, g, or t</s223></s220><s220><s221>misc_feature</s221><s222>(49)..(50)</s222><s223>n is a, c, g, or t</s223></s220></s200><s400> 197kagnnkagnn kagnnkagnn kagnnkagnn kagnnkagnn kagnnkagnn taggcatg       58</s400><s200><s210>198</s210><s211>13</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>mutated splice donor (MSD) region, deltaSL2</s223></s220></s200><s400> 198ggggcgcaaa aat                                                        13</s400></sequence-list-new-rules></sequence-cwu><?xml version="1.0" encoding="UTF-8"?><!DOCTYPE us-patent-application SYSTEM "us-patent-application-v46-2022-02-17.dtd" [ ]><us-patent-application lang="EN" dtd-version="v4.6 2022-02-17" file="US20230002778A1-20230105.XML" status="PRODUCTION" id="us-patent-application" country="US" date-produced="20221221" date-publ="20230105"><us-bibliographic-data-application lang="EN" country="US"><publication-reference><document-id><country>US</country><doc-number>20230002778</doc-number><kind>A1</kind><date>20230105</date></document-id></publication-reference><application-reference appl-type="utility"><document-id><country>US</country><doc-number>17760803</doc-number><date>20200917</date></document-id></application-reference><us-application-series-code>17</us-application-series-code><classifications-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>C</section><class>12</class><subclass>N</subclass><main-group>15</main-group><subgroup>82</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20230105</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr></classifications-ipcr><classifications-cpc><main-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>C</section><class>12</class><subclass>N</subclass><main-group>15</main-group><subgroup>8218</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20230105</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc></main-cpc><further-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>C</section><class>12</class><subclass>N</subclass><main-group>15</main-group><subgroup>8273</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20230105</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>C</section><class>12</class><subclass>N</subclass><main-group>15</main-group><subgroup>8267</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20230105</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc></further-cpc></classifications-cpc><invention-title id="d2e43">METHOD FOR IMPROVING GROWTH, STRESS TOLERANCE AND PRODUCTIVITY OF PLANT, AND INCREASING SEED QUALITY OF PLANT</invention-title><us-related-documents><us-provisional-application><document-id><country>US</country><doc-number>62901325</doc-number><date>20190917</date></document-id></us-provisional-application></us-related-documents><us-parties><us-applicants><us-applicant sequence="00" app-type="applicant" designation="us-only" applicant-authority-category="assignee"><addressbook><orgname>ACADEMIA SINICA</orgname><address><city>Taipei City</city><country>TW</country></address></addressbook><residence><country>TW</country></residence></us-applicant><us-applicant sequence="01" app-type="applicant" designation="us-only" applicant-authority-category="assignee"><addressbook><orgname>NATIONAL CENTRAL UNIVERSITY</orgname><address><city>Taoyuan City</city><country>TW</country></address></addressbook><residence><country>TW</country></residence></us-applicant></us-applicants><inventors><inventor sequence="00" designation="us-only"><addressbook><last-name>YU</last-name><first-name>Su-May</first-name><address><city>Taipei</city><country>TW</country></address></addressbook></inventor><inventor sequence="01" designation="us-only"><addressbook><last-name>CHEN</last-name><first-name>Yi-Shih</first-name><address><city>Yuanli Township</city><country>TW</country></address></addressbook></inventor><inventor sequence="02" designation="us-only"><addressbook><last-name>LU</last-name><first-name>Chung-An</first-name><address><city>Taipei City</city><country>TW</country></address></addressbook></inventor><inventor sequence="03" designation="us-only"><addressbook><last-name>HO</last-name><first-name>Tuan-Hua David</first-name><address><city>Taipei</city><country>TW</country></address></addressbook></inventor></inventors></us-parties><assignees><assignee><addressbook><orgname>ACADEMIA SINICA</orgname><role>03</role><address><city>Taipei City</city><country>TW</country></address></addressbook></assignee><assignee><addressbook><orgname>NATIONAL CENTRAL UNIVERSITY</orgname><role>03</role><address><city>Taoyuan City</city><country>TW</country></address></addressbook></assignee></assignees><pct-or-regional-filing-data><document-id><country>WO</country><doc-number>PCT/US2020/051247</doc-number><date>20200917</date></document-id><us-371c12-date><date>20220316</date></us-371c12-date></pct-or-regional-filing-data></us-bibliographic-data-application><abstract id="abstract"><p id="p-0001" num="0000">Provided herein is a method for improving growth, stress tolerance and productivity of a plant. Also provided herein is a method for increasing seed quality of a plant. Specifically, the disclosure provides a method for improving growth, stress tolerance and productivity of a plant, comprising: providing a transgenic plant, which includes a reduced expression on an MYBS2 gene as relative to its wild-type counterpart; and a method for increasing seed quality of a plant, comprising: providing a seed from a transgenic plant, which overexpresses a full-length MYBS2 gene or a mutant MYBS2 gene as relative to its wild-type counterpart.</p></abstract><drawings id="DRAWINGS"><figure id="Fig-EMI-D00000" num="00000"><img id="EMI-D00000" he="61.04mm" wi="91.27mm" file="US20230002778A1-20230105-D00000.TIF" alt="embedded image" img-content="drawing" img-format="tif"/></figure><figure id="Fig-EMI-D00001" num="00001"><img id="EMI-D00001" he="119.89mm" wi="115.57mm" file="US20230002778A1-20230105-D00001.TIF" alt="embedded image" img-content="drawing" img-format="tif"/></figure><figure id="Fig-EMI-D00002" num="00002"><img id="EMI-D00002" he="105.83mm" wi="88.14mm" file="US20230002778A1-20230105-D00002.TIF" alt="embedded image" img-content="drawing" img-format="tif"/></figure><figure id="Fig-EMI-D00003" num="00003"><img id="EMI-D00003" he="138.60mm" wi="117.43mm" file="US20230002778A1-20230105-D00003.TIF" alt="embedded image" img-content="drawing" img-format="tif"/></figure><figure id="Fig-EMI-D00004" num="00004"><img id="EMI-D00004" he="128.19mm" wi="102.62mm" file="US20230002778A1-20230105-D00004.TIF" alt="embedded image" img-content="drawing" img-format="tif"/></figure><figure id="Fig-EMI-D00005" num="00005"><img id="EMI-D00005" he="97.11mm" wi="64.09mm" file="US20230002778A1-20230105-D00005.TIF" alt="embedded image" img-content="drawing" img-format="tif"/></figure><figure id="Fig-EMI-D00006" num="00006"><img id="EMI-D00006" he="96.60mm" wi="64.43mm" file="US20230002778A1-20230105-D00006.TIF" alt="embedded image" img-content="drawing" img-format="tif"/></figure><figure id="Fig-EMI-D00007" num="00007"><img id="EMI-D00007" he="100.58mm" wi="89.58mm" file="US20230002778A1-20230105-D00007.TIF" alt="embedded image" img-content="drawing" img-format="tif"/></figure><figure id="Fig-EMI-D00008" num="00008"><img id="EMI-D00008" he="83.23mm" wi="97.62mm" file="US20230002778A1-20230105-D00008.TIF" alt="embedded image" img-content="drawing" img-format="tif"/></figure><figure id="Fig-EMI-D00009" num="00009"><img id="EMI-D00009" he="137.58mm" wi="83.90mm" file="US20230002778A1-20230105-D00009.TIF" alt="embedded image" img-content="drawing" img-format="tif"/></figure><figure id="Fig-EMI-D00010" num="00010"><img id="EMI-D00010" he="120.65mm" wi="40.98mm" file="US20230002778A1-20230105-D00010.TIF" alt="embedded image" img-content="drawing" img-format="tif"/></figure><figure id="Fig-EMI-D00011" num="00011"><img id="EMI-D00011" he="94.83mm" wi="67.90mm" file="US20230002778A1-20230105-D00011.TIF" alt="embedded image" img-content="drawing" img-format="tif"/></figure><figure id="Fig-EMI-D00012" num="00012"><img id="EMI-D00012" he="102.87mm" wi="58.59mm" file="US20230002778A1-20230105-D00012.TIF" alt="embedded image" img-content="drawing" img-format="tif"/></figure><figure id="Fig-EMI-D00013" num="00013"><img id="EMI-D00013" he="83.57mm" wi="42.25mm" file="US20230002778A1-20230105-D00013.TIF" alt="embedded image" img-content="drawing" img-format="tif"/></figure><figure id="Fig-EMI-D00014" num="00014"><img id="EMI-D00014" he="86.44mm" wi="72.47mm" file="US20230002778A1-20230105-D00014.TIF" alt="embedded image" img-content="drawing" img-format="tif"/></figure><figure id="Fig-EMI-D00015" num="00015"><img id="EMI-D00015" he="95.50mm" wi="62.40mm" file="US20230002778A1-20230105-D00015.TIF" alt="embedded image" img-content="drawing" img-format="tif"/></figure><figure id="Fig-EMI-D00016" num="00016"><img id="EMI-D00016" he="76.03mm" wi="44.53mm" file="US20230002778A1-20230105-D00016.TIF" alt="embedded image" img-content="drawing" img-format="tif"/></figure><figure id="Fig-EMI-D00017" num="00017"><img id="EMI-D00017" he="74.76mm" wi="93.30mm" file="US20230002778A1-20230105-D00017.TIF" alt="embedded image" img-content="drawing" img-format="tif"/></figure><figure id="Fig-EMI-D00018" num="00018"><img id="EMI-D00018" he="83.40mm" wi="117.94mm" file="US20230002778A1-20230105-D00018.TIF" alt="embedded image" img-content="drawing" img-format="tif"/></figure><figure id="Fig-EMI-D00019" num="00019"><img id="EMI-D00019" he="73.74mm" wi="64.52mm" file="US20230002778A1-20230105-D00019.TIF" alt="embedded image" img-content="drawing" img-format="tif"/></figure><figure id="Fig-EMI-D00020" num="00020"><img id="EMI-D00020" he="95.00mm" wi="106.51mm" file="US20230002778A1-20230105-D00020.TIF" alt="embedded image" img-content="drawing" img-format="tif"/></figure><figure id="Fig-EMI-D00021" num="00021"><img id="EMI-D00021" he="94.15mm" wi="106.85mm" file="US20230002778A1-20230105-D00021.TIF" alt="embedded image" img-content="drawing" img-format="tif"/></figure><figure id="Fig-EMI-D00022" num="00022"><img id="EMI-D00022" he="100.75mm" wi="104.48mm" file="US20230002778A1-20230105-D00022.TIF" alt="embedded image" img-content="drawing" img-format="tif"/></figure><figure id="Fig-EMI-D00023" num="00023"><img id="EMI-D00023" he="94.57mm" wi="120.31mm" file="US20230002778A1-20230105-D00023.TIF" alt="embedded image" img-content="drawing" img-format="tif"/></figure><figure id="Fig-EMI-D00024" num="00024"><img id="EMI-D00024" he="120.73mm" wi="158.92mm" file="US20230002778A1-20230105-D00024.TIF" alt="embedded image" img-content="drawing" img-format="tif"/></figure></drawings><description id="description"><?summary-of-invention description="Summary of Invention" end="lead"?><heading id="h-0001" level="1">BACKGROUND OF THE INVENTION</heading><heading id="h-0002" level="1">1. Field of the Invention</heading><p id="p-0002" num="0001">The present invention relates to a method for improving growth, stress tolerance and productivity of a plant. The present invention also relates to a method for increasing seed quality of a plant.</p><heading id="h-0003" level="1">2. The Prior Art</heading><p id="p-0003" num="0002">Being autotrophic organisms, plants constantly monitor and respond to sugar status to maintain sugar homeostasis that is crucial for growth regulation, tolerance to environmental stresses and productivity. Mechanisms have evolved in plants in response to fluctuating sugar levels by adjusting metabolism to balance physiology. Sugar homeostasis, from the production of sugars in source tissues to their utilization or storage in sink tissues, is tightly coordinated through an integrated signaling network, involving crosstalk among sugars, hormones, and environmental cues, to regulate developmental and stress-adaptive processes. Sugars modulate nearly all fundamental processes throughout the entire lifecycle of plants. In general, sugar provision up-regulates genes involved in biosynthesis, transport, storage of reserves and cell growth, and it down-regulates those associated with photosynthesis, reserve mobilization and stress responses, but sugar starvation has the opposite effects.</p><p id="p-0004" num="0003">Upon assimilation in photosynthetic source leaves, newly fixed carbon is utilized for cellular respiration and metabolism, transiently stored in vacuoles as sucrose or in plastids as starch, and transported as sucrose to sink tissues such as growing tissues (to generate energy) or developing organs (for long-term storage). Despite sugars being of central importance to plant growth, too much of them can be detrimental. For instance, ectopic expression of a yeast invertase, which converts sucrose to glucose and fructose in the apoplast, leads to decreased sucrose export and accumulation of carbohydrates in leaves, with subsequent inhibition of photosynthesis, stunted growth, impaired root formation, and necrosis in tobacco leaves. Rice and maize mutant lines defective in a tonoplast sucrose transporter, SUT2, accumulate higher concentrations of sugars in leaves but exhibit growth retardation and reduced biomass and grain yield, presumably due to reduced transport of sucrose out of vacuoles in source leaves to sink tissues/organs where sugar is in high demand.</p><p id="p-0005" num="0004">Sugar starvation-induced nutrient recycling represents an essential strategy for survival or continuous growth under adverse environments. Plants undergo sugar starvation at certain times of their life cycles and in some of their non-green organs (such as roots, stems and flowers that do not carry out photosynthesis). Furthermore, sugar starvation or depletion can occur under extreme environmental conditions or upon attack by pathogens or pests that lead to significantly decreased photosynthetic efficiency, 110 or during a quiescent period or after leaf-shedding when photosynthesis is switched off. During prolonged darkness, sugar starvation drives a profound metabolic readjustment and initiates an autophagic pathway for partial degradation of chloroplast in vacuoles to recycle amino acids and other molecules that can be used to feed young tissues and produce seeds.</p><p id="p-0006" num="0005">Starch, which constitutes approximately 75% of cereal grain dry weight, provides the major carbon source for generating energy and metabolites during germination and seedling growth. &#x3b1;Amy is the most abundant hydrolase and plays a central role in starch mobilization and thus the rate of seedling growth. Our previous studies in rice revealed that sugar starvation up-regulates &#x3b1;Amy expression by controlling its transcription rate and mRNA stability. &#x3b1;Amy transcriptional regulation is mediated through a sugar response complex (SRC) in &#x3b1;Amy promoters, in which the TA box is a key cis-acting element. MYBS1 is a single DNA binding repeat (R1) MYB transcription factor that interacts with the TA box and induces &#x3b1;Amy promoter under sugar starvation. Sugar starvation activates MYBS1 expression and promotes its nuclear import, whereas sugar provision has opposite effects.</p><p id="p-0007" num="0006">GA activates &#x3b1;Amy promoters through the GA response complex (GARC), in which the adjacent GA response element (GARE) and TA box are key elements that act synergistically. The MYBS1-TA box interaction is essential for GARC and SRC functions, demonstrating that MYBS1 is a crucial node in GA and sugar starvation cross-signaling. In rice and barley, MYBGA is a GA-inducible R2R3 MYB transcriptional factor that binds the GARE and activates &#x3b1;Amy and hydrolase promoters in aleurone cells surrounding the starchy endosperm. GA antagonizes sugar-mediated repression of &#x3b1;Amy expression by enhancing co-nuclear transport of MYBGA and MYBS1 and formation of a stable bipartite MYB-DNA complex to activate &#x3b1;Amy and hydrolase gene promoters.</p><p id="p-0008" num="0007">The 14-3-3 protein family is a highly conserved group of dimeric proteins that dock onto phosphorylated serine (Ser) and threonine (Thr) residues in their target proteins. In plants, target proteins of 14-3-3 proteins are involved in signal transduction and gene regulation of various biological processes, and binding of client proteins by 14-3-3 proteins may lead to conformational change, alternation of activity and stability, or sequestration in subcellular compartments. Involvement of 14-3-3 proteins in sugar regulation has been reported in yeast cells. In <i>Saccharomyces cerevisiae</i>, a 14-3-3 protein (Bmh1) is required for interaction with an HSP70 (Ssb) for recruiting a phosphatase (Glc7) to dephosphorylate and inactivate the protein kinase SNF1, a process necessary for glucose repression. In plants, 14-3-3 protein-mediated regulation of sugar homeostasis has not been explored.</p><p id="p-0009" num="0008">Previously, we identified another R1 MYB transcription factor, MYBS2, which is up-regulated by sugars and also binds to the TA box of &#x3b1;Amy promoters. Here, by using &#x3b1;Amy as a biochemical marker, we showed that sugar provision/starvation counteract each other by regulating the competition between MYB S1 and MYB S2 for binding to the TA box as transcriptional activator and repressor of &#x3b1;Amy promoter, respectively. Particularly, phosphorylation regulates the sugar-dependent nucleocytoplasmic shuttling of MYBS2 and its cytoplasmic interaction with 14-3-3 proteins, which plays a critical role regulating the on/off switch of reversible gene expression to maintain sugar homeostasis. We also observed that manipulation of MYBS2 and &#x3b1;Amy can lead to beneficial effects on plant growth, tolerance to stress and grain productivity, which offers a novel approach to crop improvement.</p><heading id="h-0004" level="1">SUMMARY OF THE INVENTION</heading><p id="p-0010" num="0009">A primary objective of the present invention is to provide a method for improving growth, stress tolerance and productivity of a plant, comprising: (a) providing a transgenic plant, which includes a reduced expression on an MYBS2 gene as relative to its wild-type counterpart; and (b) growing the transgenic plant in a normal environment or an environment comprising an abiotic stress factor.</p><p id="p-0011" num="0010">According to an embodiment of the present invention, the transgenic plant further includes an increased expression on an &#x3b1;Amy3 gene as relative to its wild-type counterpart.</p><p id="p-0012" num="0011">According to an embodiment of the present invention, the MYBS2 gene encodes an MYBS2 transcription factor, and the MYBS2 transcription factor binds to a TA box in a promoter of the &#x3b1;Amy3 gene.</p><p id="p-0013" num="0012">According to an embodiment of the present invention, the plant is a monocotyledonous plant or a dicotyledonous plant.</p><p id="p-0014" num="0013">According to an embodiment of the present invention, the dicotyledonous plant is selected from the group consisting of <i>Cucumis sativus, Ricinus communis, Solanum lycopersicum, Solanum tuberosum, Vitis vinifera, Populus trichocarpa, Arabidopsis thaliana, Arabidopsis lyrata</i>, and <i>Platycodon grandiflorus. </i></p><p id="p-0015" num="0014">According to an embodiment of the present invention, the plant is a crop.</p><p id="p-0016" num="0015">According to an embodiment of the present invention, the crop is rice, maize, wheat, barley, sugarcane, banana, cotton, soybean, pea, potato, tomato, brassica, orchid, balloon flower, yam, sweet potato, cassava, rose, petunia, chrysanthemum, lily, or carnation.</p><p id="p-0017" num="0016">According to an embodiment of the present invention, the plant is an angiosperm.</p><p id="p-0018" num="0017">According to an embodiment of the present invention, the MYBS2 gene encodes an MYBS2 transcription factor, and the MYBS2 transcription factor binds to a TA box in a promoter of the &#x3b1;Amy3 gene.</p><p id="p-0019" num="0018">According to an embodiment of the present invention, the abiotic stress factor is osmotic stress, salt, dehydration, or heat.</p><p id="p-0020" num="0019">Another objective of the present invention is to provide a method for increasing seed quality of a plant, comprising: (a) providing a seed from a transgenic plant, which overexpresses a full-length MYBS2 gene or a mutant MYBS2 gene as relative to its wild-type counterpart; and (b) growing the seed in a normal environment or an environment comprising an abiotic stress factor.</p><p id="p-0021" num="0020">According to an embodiment of the present invention, the seed includes a reduced expression on an &#x3b1;Amy3 gene as relative to its wild-type counterpart.</p><p id="p-0022" num="0021">According to an embodiment of the present invention, the mutant MYBS2 gene encodes a truncated MYBS2 transcription factor which includes deletion of 1st-53rd amino acid residues.</p><p id="p-0023" num="0022">According to an embodiment of the present invention, the plant is a monocotyledonous plant or a dicotyledonous plant.</p><p id="p-0024" num="0023">According to an embodiment of the present invention, the monocotyledonous plant is selected from the group consisting of <i>Zea mays, Sorghum bicolor, Setaria italica, Hordeum vulgare, Brachypodium distachyon, Oryza sativa, Triticum </i>spp., and <i>Saccharum </i>spp.</p><p id="p-0025" num="0024">According to an embodiment of the present invention, the dicotyledonous plant is selected from the group consisting of <i>Cucumis sativus, Ricinus communis, Solanum lycopersicum, Solanum tuberosum, Vitis vinifera, Populus trichocarpa, Arabidopsis thaliana, Arabidopsis lyrata</i>, and <i>Platycodon grandiflorus. </i></p><p id="p-0026" num="0025">According to an embodiment of the present invention, the plant is a crop.</p><p id="p-0027" num="0026">According to an embodiment of the present invention, the crop is rice, maize, wheat, barley, sugarcane, banana, cotton, soybean, pea, potato, tomato, brassica, orchid, balloon flower, yam, sweet potato, cassava, rose, petunia, chrysanthemum, lily, or carnation.</p><p id="p-0028" num="0027">According to an embodiment of the present invention, the plant is an angiosperm.</p><p id="p-0029" num="0028">According to an embodiment of the present invention, the abiotic stress factor is osmotic stress, salt, dehydration, or heat.</p><p id="p-0030" num="0029">In summary, the present invention providing a method for improving growth, stress tolerance and productivity of a plant, and a method for increasing seed quality of a plant has the benefits on promoting plant growth and/or yield under normal or stressed conditions to cope with global water shortage in farmland and global climate warming, protecting plants from damages caused by water deficit, maintaining grain productivity under non-stressed and stressed conditions, maintaining high quality rice grain under global warming, enhancing public acceptance of new varieties and their products, reducing the transparency of milled rice to provide good sake-brewing rice for wine industry, enhancing transparency of milled rice for global market demand for high quality rice, maintaining the sugar homeostasis in plant, increasing sugar contents and stress tolerance, and generating new varieties to drought in various plant species.</p><?summary-of-invention description="Summary of Invention" end="tail"?><?brief-description-of-drawings description="Brief Description of Drawings" end="lead"?><description-of-drawings><heading id="h-0005" level="1">BRIEF DESCRIPTION OF THE DRAWINGS</heading><p id="p-0031" num="0030">The following drawings form part of the present specification and are included here to further demonstrate some aspects of the present invention, which can be better understood by reference to one or more of these drawings, in combination with the detailed description of the embodiments presented herein.</p><p id="p-0032" num="0031"><figref idref="DRAWINGS">FIG. <b>1</b>A</figref> is a data diagram demonstrating MYBS2 is a negative regulator of germination and plant growth, and suppresses &#x3b1;Amy expression, in which total mRNA were extracted from leaves of 7-day-old seedlings of transgenic lines overexpressing (Ox) or underexpressing (Ri) Ubi:MYBS2 and subjected to qRT-PCR analysis; the inset shows comparison of MYBS2 mRNA levels between sWT and Ri lines.</p><p id="p-0033" num="0032"><figref idref="DRAWINGS">FIG. <b>1</b>B</figref> is a data diagram demonstrating MYBS2 is a negative regulator of germination and plant growth, and suppresses &#x3b1;Amy expression, in which seeds were germinated in &#xbd; MS medium without sugars at 28&#xb0; C. for 5 days, before determining germination rates. Error bars represent standard deviation (SD).</p><p id="p-0034" num="0033"><figref idref="DRAWINGS">FIG. <b>1</b>C</figref> is a data diagram demonstrating MYBS2 is a negative regulator of germination and plant growth, and suppresses &#x3b1;Amy expression, in which two-day-old seedlings of sWT and MYBS2 Ox and Ri lines with similar shoot lengths were grown in &#xbd; MS for up to 14 days; seedling growth was determined by measuring shoot length.</p><p id="p-0035" num="0034"><figref idref="DRAWINGS">FIG. <b>1</b>D</figref> is a data diagram demonstrating MYBS2 is a negative regulator of germination and plant growth, and suppresses &#x3b1;Amy expression, in which two-day-old seedlings of sWT and MYBS2 Ox and Ri lines with similar shoot lengths were grown in &#xbd; MS for up to 14 days; seedling growth was determined by measuring shoot length.</p><p id="p-0036" num="0035"><figref idref="DRAWINGS">FIG. <b>1</b>E</figref> is a photograph demonstrating MYBS2 is a negative regulator of germination and plant growth, and suppresses &#x3b1;Amy expression, in which plants in <figref idref="DRAWINGS">FIG. <b>1</b>C</figref> and <figref idref="DRAWINGS">FIG. <b>1</b>D</figref> were transferred to a greenhouse for continuous growth and the morphology of 90-day-old plants was assessed.</p><p id="p-0037" num="0036"><figref idref="DRAWINGS">FIG. <b>1</b>F</figref> is a photograph demonstrating MYBS2 is a negative regulator of germination and plant growth, and suppresses &#x3b1;Amy expression, in which plants in <figref idref="DRAWINGS">FIG. <b>1</b>C</figref> and <figref idref="DRAWINGS">FIG. <b>1</b>D</figref> were transferred to a greenhouse for continuous growth and the morphology of 90-day-old plants was assessed.</p><p id="p-0038" num="0037"><figref idref="DRAWINGS">FIG. <b>2</b>A</figref> is a data diagram demonstrating MYBS2 represses &#x3b1;Amy promoter activities through the TA box, in which seedlings of sWT, MYBS2 (full-length or truncated cDNA) (XM_015757381.2) Ox and Ri lines were cultured in &#xbd; MS medium without sugar for 10 days; total RNAs were extracted from leaves and used for qRT-PCR analysis using &#x3b1;Amy3-specific primers.</p><p id="p-0039" num="0038"><figref idref="DRAWINGS">FIG. <b>2</b>B</figref> is a schematic diagram demonstrating MYBS2 represses &#x3b1;Amy promoter activities through the TA box, in which rice embryo calli were co-transfected with effector (XM_015757381.2, AK068565) and reporter plasmids (see Chung-An Lu et al., (2002), <i>Plant Cell, </i>14(8): 1963-1980), incubated in &#x2212;S medium for 24 h, before assaying for luciferase activity. The value for luciferase activity of the reporter construct in the absence of the effector was set to 1&#xd7;, and all other values were calculated relative to this value. Error bar indicates the standard error (SE) for three replicate experiments. Effector constructs in rice embryo calli carrying reporter constructs &#x3b1;Amy3-35Smp:Luc and 6&#xd7;TA-35Smp:Luc (see Chung-An Lu et al., (2002), <i>Plant Cell, </i>14(8): 1963-1980) in the presence of effector constructs.</p><p id="p-0040" num="0039"><figref idref="DRAWINGS">FIG. <b>2</b>C</figref> is a schematic diagram demonstrating MYBS2 represses &#x3b1;Amy promoter activities through the TA box, in which rice embryo calli were co-transfected with effector (XM_015757381.2, AK068565) and reporter plasmids (see Chung-An Lu et al., (2002), <i>Plant Cell, </i>14(8): 1963-1980), incubated in &#x2212;S medium for 24 h, before assaying for luciferase activity. The value for luciferase activity of the reporter construct in the absence of the effector was set to 1&#xd7;, and all other values were calculated relative to this value. Error bar indicates the standard error (SE) for three replicate experiments. Luciferase activities of in rice embryo calli carrying reporter constructs &#x3b1;Amy3-35Smp:Luc and 6&#xd7;TA-35Smp:Luc (see Chung-An Lu et al., (2002), <i>Plant Cell, </i>14(8): 1963-1980) in the presence of effector constructs.</p><p id="p-0041" num="0040"><figref idref="DRAWINGS">FIG. <b>3</b>A</figref> is a data diagram demonstrating reduced MYBS2 expression upregulates &#x3b1;Amy3 under abiotic stress, and ectopic expression of &#x3b1;Amy3 enhances osmotic stress tolerance in rice, in which ten-day-old seedlings of sWT rice were treated with the indicated abiotic stress; total RNAs were extracted for qRT-PCR analysis using &#x3b1;Amy3- and MYBS2-specific primers; upper and lower panels show the expression of MYBS2 and &#x3b1;Amy3, respectively; CK: untreated control.</p><p id="p-0042" num="0041"><figref idref="DRAWINGS">FIG. <b>3</b>B</figref> is a data diagram demonstrating reduced MYBS2 expression upregulates &#x3b1;Amy3 under abiotic stress, and ectopic expression of &#x3b1;Amy3 enhances osmotic stress tolerance in rice, in which seeds of transgenic rice overexpressing Ubi: &#x3b1;Amy3 or &#x3b1;Amy3: &#x3b1;Amy3 were germinated in &#xbd; MS medium without 400 mM sorbitol; germination rates were determined every day up to day 5; germination and plant growth without sorbitol treatment (&#x2212;sorbitol).</p><p id="p-0043" num="0042"><figref idref="DRAWINGS">FIG. <b>3</b>C</figref> is a data diagram demonstrating reduced MYBS2 expression upregulates &#x3b1;Amy3 under abiotic stress, and ectopic expression of &#x3b1;Amy3 enhances osmotic stress tolerance in rice, in which seeds of transgenic rice overexpressing Ubi: &#x3b1;Amy3 or &#x3b1;Amy3: &#x3b1;Amy3 were germinated in &#xbd; MS medium without 400 mM sorbitol; shoot length was determined at day 8; error bars represent SD (n=10); germination and plant growth without sorbitol treatment (&#x2212;sorbitol).</p><p id="p-0044" num="0043"><figref idref="DRAWINGS">FIG. <b>3</b>D</figref> is a photograph demonstrating reduced MYBS2 expression upregulates &#x3b1;Amy3 under abiotic stress, and ectopic expression of &#x3b1;Amy3 enhances osmotic stress tolerance in rice, in which seeds of transgenic rice overexpressing Ubi: &#x3b1;Amy3 or &#x3b1;Amy3: &#x3b1;Amy3 were germinated in &#xbd; MS medium without 400 mM sorbitol; plant morphology was photographed at day 8; germination and plant growth without sorbitol treatment (&#x2212;sorbitol).</p><p id="p-0045" num="0044"><figref idref="DRAWINGS">FIG. <b>3</b>E</figref> is a data diagram demonstrating reduced MYBS2 expression upregulates &#x3b1;Amy3 under abiotic stress, and ectopic expression of &#x3b1;Amy3 enhances osmotic stress tolerance in rice, in which seeds of transgenic rice overexpressing Ubi: &#x3b1;Amy3 or &#x3b1;Amy3: &#x3b1;Amy3 were germinated in &#xbd; MS medium with 400 mM sorbitol; germination rates were determined every day up to day 5; error bars represent SD (n=10); germination and plant growth with sorbitol treatment (+sorbitol).</p><p id="p-0046" num="0045"><figref idref="DRAWINGS">FIG. <b>3</b>F</figref> is a data diagram demonstrating reduced MYBS2 expression upregulates &#x3b1;Amy3 under abiotic stress, and ectopic expression of &#x3b1;Amy3 enhances osmotic stress tolerance in rice, in which seeds of transgenic rice overexpressing Ubi: &#x3b1;Amy3 or &#x3b1;Amy3: &#x3b1;Amy3 were germinated in &#xbd; MS medium with 400 mM sorbitol; shoot length was determined at day 8; error bars represent SD (n=10); asterisks indicate significant differences (Student's t-test, *P&#x3c;0.05, **P&#x3c;0.01, ***P&#x3c;0.001); germination and plant growth with sorbitol treatment (+sorbitol).</p><p id="p-0047" num="0046"><figref idref="DRAWINGS">FIG. <b>3</b>G</figref> is a photograph demonstrating reduced MYBS2 expression upregulates &#x3b1;Amy3 under abiotic stress, and ectopic expression of &#x3b1;Amy3 enhances osmotic stress tolerance in rice, in which seeds of transgenic rice overexpressing Ubi: &#x3b1;Amy3 or &#x3b1;Amy3: &#x3b1;Amy3 were germinated in &#xbd; MS medium with 400 mM sorbitol; plant morphology was photographed at day 8; germination and plant growth with sorbitol treatment (+sorbitol).</p><p id="p-0048" num="0047"><figref idref="DRAWINGS">FIG. <b>4</b>A</figref> is a schematic diagram demonstrating reduced MYBS2 expression enhances osmotic and drought stress tolerance and grain yield in rice, in which ten-day-old seedlings were treated with 15% PEG for 7 days and 20% PEG for another 16 days before determining the survival rate; n=10; sWT, MYBS2-Ox, MYBS2(54-265)-Ox, and MYBS2-Ri lines were used.</p><p id="p-0049" num="0048"><figref idref="DRAWINGS">FIG. <b>4</b>B</figref> is a schematic diagram demonstrating reduced MYBS2 expression enhances drought stress tolerance in rice, in which ten-day-old seedlings were transferred to soil with regular water for 3 weeks, before cessation of watering for the next 21 days, and then the survival rate was determined; n=10; sWT, MYBS2-Ox, MYBS2(54-265)-Ox, and MYBS2-Ri lines were used.</p><p id="p-0050" num="0049"><figref idref="DRAWINGS">FIG. <b>4</b>C</figref> is a data diagram demonstrating reduced MYBS2 expression enhances grain yield in rice, in which grain yield of rice grown in field; n=12, significance levels with the t-test: *P&#x3c;0.05, **P&#x3c;0.01, ***P&#x3c;0.001.</p><p id="p-0051" num="0050"><figref idref="DRAWINGS">FIG. <b>4</b>D</figref> is a data diagram demonstrating reduced MYBS2 expression enhances grain yield in rice in which grain yield of rice grown in field. *P&#x3c;0.05, **P&#x3c;0.01, ***P&#x3c;0.001.</p><p id="p-0052" num="0051"><figref idref="DRAWINGS">FIG. <b>4</b>E</figref> is a data diagram demonstrating reduced MYBS2 expression enhances grain yield in rice in which grain yield of rice grown in greenhouse.**P&#x3c;0.01, ***P&#x3c;0.001.</p><p id="p-0053" num="0052"><figref idref="DRAWINGS">FIG. <b>4</b>F</figref> is a data diagram demonstrating reduced MYBS2 expression enhances grain yield in rice in which grain yield of rice grown in greenhouse. *P&#x3c;0.05, **P&#x3c;0.01, ***P&#x3c;0.001.</p><p id="p-0054" num="0053"><figref idref="DRAWINGS">FIG. <b>4</b>G</figref> is a data diagram demonstrating reduced MYBS2 expression enhances grain yield in rice, wherein sWT, OX-1, OX-2, OX-3, OX-(tr)-1, OX-(tr)-2, RNAi-1, RNAi-2, and MYBS2-Cas9 (knock out) lines were used to analyze grain weight of rice in 2020 (field).</p><p id="p-0055" num="0054"><figref idref="DRAWINGS">FIG. <b>5</b></figref> is a schematic diagram demonstrating overexpression of MYBS2 reduces the chalky grains (i.e., increasing rice quality) while reduced expression of MYBS2 (or overexpression of &#x3b1;Amy3) increases the chalky grains.</p></description-of-drawings><?brief-description-of-drawings description="Brief Description of Drawings" end="tail"?><?detailed-description description="Detailed Description" end="lead"?><heading id="h-0006" level="1">DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT</heading><p id="p-0056" num="0055">In the following detailed description of the embodiments of the present invention, reference is made to the accompanying drawings, which are shown to illustrate the specific embodiments in which the present disclosure may be practiced. These embodiments are provided to enable those skilled in the art to practice the present disclosure. It is understood that other embodiments may be used and that changes can be made to the embodiments without departing from the scope of the present invention. The following description is therefore not to be considered as limiting the scope of the present invention.</p><p id="p-0057" num="0056">Sugar homeostasis is a unique feature in autotrophic plants where sugars are constantly generated and utilized. Plants have evolved mechanisms to cope with the fluctuation of sugar levels by adjusting metabolisms to balance physiological responses. The on/off switch of reversible gene expression by sugar starvation/provision represents a major mechanism for maintaining sugar homeostasis, however, details of the mechanism remain unclear. &#x3b1;-Amylase (&#x3b1;Amy) is the key enzyme hydrolyzing starch to provide sugars for plant growth, thus subject to sugar homeostasis regulation: induction by sugar starvation and repression by sugar provision. &#x3b1;Amy is induced by various stresses, but its physiological significance is also unclear. Here we discovered that the on/off switch of &#x3b1;Amy expression is regulated by two MYB transcription factors competing for the same promoter element; with MYBS1 promoting yet MYBS2 repressing &#x3b1;Amy expression. Sugar starvation promotes nuclear import of MYBS1 but nuclear export of MYBS2, and vice versa with sugar provision. Phosphorylation of MBYS2 at distinct serine residues plays critical roles in regulating its sugar-dependent nucleocytoplasmic shuttling and retaining by 14-3-3 proteins in the cytoplasm. Moreover, expression of MYBS2 is repressed by dehydration and heat, causing induction of &#x3b1;Amy3, yet activation of &#x3b1;Amy3 and suppression of MYBS2 leads to enhanced plant growth, stress tolerance and grain yield in rice. The present invention reveals unique insights into a critical regulatory mechanism for an on/off switch of reversible gene expression in maintaining sugar homeostasis, which tightly regulates plant growth and development, and also highlights MYBS2 and &#x3b1;Amy3 as potential targets for crop improvement.</p><p id="p-0058" num="0057">Being autotrophic organisms, plants constantly monitor and respond to sugar status to maintain sugar homeostasis that is crucial for growth regulation, tolerance to environmental stresses and productivity. &#x3b1;Amy is the key enzyme hydrolyzing starch to sugars, thus subject to sugar homeostasis regulation: induction by sugar starvation but repression by sugar provision. Two MYBs compete for binding to the same promoter element and regulate this counteracting regulatory process, with MYBS1 promoting but MBYS2 repressing &#x3b1;Amy expression. Induction of &#x3b1;Amy expression by suppression of MYBS2 leads to enhanced stress tolerance and productivity. Phosphorylation of MBYS2 plays critical roles in regulating its sugar-dependent nucleocytoplasmic shuttling and interactions with 14-3-3 proteins, which constitutes a novel regulatory mechanism for reversible gene expression by sugar homeostasis.</p><p id="p-0059" num="0058">During plant growth and development, sugar supply and starvation contrastingly regulate gene expression temporally and spatially, which play a pivotal role in determining crop productivity and quality. We identified MYBS2, a sugar inducible transcription factor that negatively regulates plant growth and development, by binding to the TA box and suppressing &#x3b1;Amy promoter activity. The MYBS2 promoter is specifically active in rice tissues rich in sugars. The present invention demonstrates that MYBS2 regulates sugar hemostasis in rice, and reveals that reduced MYBS2 expression leads to increased accumulation of &#x3b1;-amylase gene (&#x3b1;Amy3) expression, which in turn enhances plant growth, abiotic stress tolerance and grain yield in rice. The purpose of the present invention is to manipulate the expression of MYBS2 and &#x3b1;Amy3 to improve growth, abiotic stress tolerance, and grain yield in rice and other plant species.</p><heading id="h-0007" level="1">Definition</heading><p id="p-0060" num="0059">Numerical quantities given herein are approximate, and experimental values may vary within 20 percent, preferably within 10 percent, and most preferably within 5 percent. Thus, the terms &#x201c;about&#x201d; and &#x201c;approximately&#x201d; refer to within 20 percent, preferably within 10 percent, and most preferably within 5 percent of a given value or range.</p><heading id="h-0008" level="2">Materials and Methods</heading><heading id="h-0009" level="2">Plant Materials</heading><p id="p-0061" num="0060">Rice (<i>Oryza sativa </i>cv Tainung 67) and barley (<i>Hordeum vulgare </i>cv Himalaya) were used in the present invention. Seedlings were grown in growth chambers under a 16-h light and 8-h dark cycle at 28&#xb0; C.</p><p id="p-0062" num="0061">Prior arts showed that sugar regulation of MYBS1 function in barley aleurone, SnRK1A (see Chung-An Lu et al., (2002), <i>Plant Cell, </i>14(8): 1963-1980; Chung-An Lu et al., (2007), <i>Plant Cell, </i>19(8): 2484-2499; Kuo-Wei Lee et al., (2009), <i>Sci Signal, </i>2(91):ra61; Ya-Fang Hong et al., (2012), <i>Plant Cell, </i>24(7):2857-73; Alan H. Christensen and Peter H. Quail, (1996), <i>Transgenic Research</i>, volume 5, pages 213-218) regulation of MYBS1 function using rice embryo calli, CIPK15 regulation of SnRK1A expression using rice suspension cells, regulation of MYBS1 and MYBGA interaction and nucleocytoplasmic shuttling of MYBS1 using rice and barley aleurones, and regulation of activity and nucleocytoplasmic shuttling of SnRK1A and MYBS1 using rice embryo calli and barley aleurones are all consistent, regardless of different systems being used. For our transient expression assay of luciferase activity, we chose to use rice embryo calli because they are easier to manipulate for large-scale sample preparation, particle bombardment and protein extraction.</p><heading id="h-0010" level="2">Primers</heading><p id="p-0063" num="0062">Primers for plasmid construction and RT-PCR analyses are listed in Table 1 and Table 2.</p><p id="p-0064" num="0000"><tables id="TABLE-US-00001" num="00001"><table frame="none" colsep="0" rowsep="0" tabstyle="monospace"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="217pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE&#x2003;1</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Primers&#x2003;for&#x2003;RT-PCR&#x2003;and&#x2003;qRT-PCR&#x2003;analyses</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="3"><colspec colname="1" colwidth="42pt" align="left"/><colspec colname="2" colwidth="112pt" align="left"/><colspec colname="3" colwidth="63pt" align="left"/><tbody valign="top"><row><entry>Primers</entry><entry>Nucleotide&#x2003;sequence&#x2003;(5&#x2032;&#x2192;3&#x2032;)</entry><entry>Purpose</entry></row><row><entry namest="1" nameend="3" align="center" rowsep="1"/></row><row><entry>3RT25A</entry><entry>GTAGGCAGGCTCTCTAGCCTCTAGG</entry><entry>&#x3b1;Amy3&#x2003;RT-PCR</entry></row><row><entry>(F)</entry><entry>(SEQ&#x2003;ID&#x2003;NO:&#x2003;1)</entry><entry>and&#x2003;real-time</entry></row><row><entry>3RT(R)</entry><entry>AACCTGACATTATATATTGCACC</entry><entry>RT-PCR</entry></row><row><entry/><entry>(SEQ&#x2003;ID&#x2003;NO:&#x2003;2)</entry><entry/></row><row><entry> </entry></row><row><entry>8RT1(F)</entry><entry>CTCAGGGTTCCTGCCGGTAGAAAGCA</entry><entry>&#x3b1;Amy&#x2003;8&#x2003;RT-PCR</entry></row><row><entry/><entry>(SEQ&#x2003;ID&#x2003;NO:&#x2003;3)</entry><entry>and&#x2003;real-time</entry></row><row><entry>8RTB(R)</entry><entry>CGAAACGAACAGTAGCTAG</entry><entry>RT-PCR</entry></row><row><entry/><entry>(SEQ&#x2003;ID&#x2003;NO:&#x2003;4)</entry><entry/></row><row><entry> </entry></row><row><entry>S2QF</entry><entry>CAGACCAACCCTGGCAAAAA</entry><entry>MYBS2&#x2003;real-</entry></row><row><entry/><entry>(SEQ&#x2003;ID&#x2003;NO:&#x2003;5)</entry><entry>time&#x2003;RT-PCR</entry></row><row><entry>S2QR</entry><entry>GAGGACTTGGAAGCTGATCATCA</entry><entry/></row><row><entry/><entry>(SEQ&#x2003;ID&#x2003;NO:&#x2003;6)</entry><entry/></row><row><entry> </entry></row><row><entry>UBQ5(F)</entry><entry>ACCACTTCGACCGCCACTACT</entry><entry>RT-PCR&#x2003;and&#x2003;</entry></row><row><entry/><entry>(SEQ&#x2003;ID&#x2003;NO:&#x2003;7)</entry><entry>real-time</entry></row><row><entry>UBQ5(R)</entry><entry>ACGCCTAAGCCTGCTGGTT</entry><entry>RT-PCR</entry></row><row><entry/><entry>(SEQ&#x2003;ID&#x2003;NO:&#x2003;8)</entry></row><row><entry namest="1" nameend="3" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><p id="p-0065" num="0000"><tables id="TABLE-US-00002" num="00002"><table frame="none" colsep="0" rowsep="0" tabstyle="monospace"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="217pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE&#x2003;2</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Primers&#x2003;for&#x2003;plasmid&#x2003;constructions&#x2003;and&#x2003;DNA&#x2003;sequence</entry></row><row><entry>mutation</entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="3"><colspec colname="1" colwidth="49pt" align="left"/><colspec colname="2" colwidth="126pt" align="left"/><colspec colname="3" colwidth="42pt" align="left"/><tbody valign="top"><row><entry>Primers</entry><entry>Nucleotide&#x2003;sequence&#x2003;(5&#x2032;&#x2192;3&#x2032;)</entry><entry>Purpose</entry></row><row><entry namest="1" nameend="3" align="center" rowsep="1"/></row><row><entry>S2F&#x2003;Not1</entry><entry>GCGCGGCCGCACCATGGAGCAGCATGAGGA</entry><entry>Ubi:</entry></row><row><entry>F</entry><entry>GGC&#x2003;(SEQ&#x2003;ID&#x2003;NO:9)</entry><entry>S2-Nos,</entry></row><row><entry> </entry></row><row><entry>S2F&#x2003;BglII</entry><entry>GCAGATCTTCACAGCACCTTGATGGCCGCC</entry><entry>Ubi:</entry></row><row><entry>R</entry><entry>(SEQ&#x2003;ID&#x2003;NO:&#x2003;10)</entry><entry>S2-Nos</entry></row><row><entry> </entry></row><row><entry>tr&#x2003;S2Not1</entry><entry>GCGCGGCCGCATGCCCAACCTCACCTCCA</entry><entry>Ub:</entry></row><row><entry>F</entry><entry>(SEQ&#x2003;ID&#x2003;NO:&#x2003;11)</entry><entry>(tr)MYBS2-</entry></row><row><entry> </entry></row><row><entry>tr&#x2003;S2bgl1</entry><entry>GCAGATCTCAGCACCTTGATGGCCG</entry><entry>Nos,</entry></row><row><entry>R</entry><entry>(SEQ&#x2003;ID&#x2003;NO:&#x2003;12)</entry></row><row><entry namest="1" nameend="3" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><heading id="h-0011" level="2">Plasmids</heading><p id="p-0066" num="0063">Plasmid p6XTA containing six copies of the fragment comprising positions &#x2212;134 to &#x2212;82 upstream of the transcription start site of &#x3b1;Amy3 (SEQ ID NO: 21) was fused to CaMV35S minimal promoter (SEQ ID NO: 18)-luciferase gene (Luc)(see Chung-An Lu et al., (2002), <i>Plant Cell, </i>14(8): 1963-1980). Plasmid pUG containing the Ubiquitin (Ubi) promoter fused to the &#x3b2;-glucuronidase gene (GUS) was used as an internal control for transient expression assay. Plasmid p3Luc.18 contains &#x3b1;Amy3 SRC (&#x2212;186 to &#x2212;82 upstream of the transcription start site) fused to the CaMV35S minimal promoter-Adh1 intron-Luc cDNA fusion gene.</p><heading id="h-0012" level="2">Plasmid Construction</heading><p id="p-0067" num="0064">For overexpression of the full-length MYBS2 (SEQ ID NO: 13) and N-terminal-deleted MYBS2 (tr) in transgenic rice, MYBS2 cDNA fragments (AK121235) containing nucleotides 1-795 (full-length version) and nucleotides 160-795 (truncated version)(SEQ ID NO: 14) was inserted downstream of the Ubi promoter and upstream of the Nos terminator (SEQ ID NO: 19), generating pU-MYBS2 and pU-MYBS2(tr)(see Manuel Cerc&#xf3;s et al., (2002), the plant journal, doi.org/10.1046/j.1365-313X.1999.00499.x). The two plasmids were digested with HindIII and inserted into the binary vector pCambia1301 (CAMBIA) at the same site, generating pAU-MYBS2 and pAU-MYBS2(tr)(AK121235). The amino sequence of the full length MYBS2 transcription factor is SEQ ID NO: 22.</p><p id="p-0068" num="0065">For knockdown and knockout of MYBS2 in transgenic rice, we generated the MYBS2 RNA interference (RNAi) construct using a 485-bp (SEQ ID NO: 15) partial cDNA fragment of the MYBS2 3&#x2032;UTR and the MYBS2 CRISPR-Cas9 construct using a 24 bp guide RNA sequence targeting MYBS2, respectively. For the MYBS2 RNA interference (RNAi) construct, the MYBS2 cDNA fragment was fused to the green fluorescent protein gene (GFP) and then inserted into the pSMY1H binary vector (AK121235); and for the knockout of MYBS2, the 24 bp MYBS2 guide RNA sequence was inserted into the pRGEB31 binary vector.</p><p id="p-0069" num="0066">To generate common destination vectors for construction of plasmids used in our transient expression assays, we digested plasmid pAHC18 with BamHI to remove the Luc cDNA insert, before inserting the Not1, BglII and Spe1 restriction site sequences between the Ubi or CaMV35S promoter and the Nos terminator, generating destination vectors pUbi-Not1-BglII-SpeI-Nos.</p><heading id="h-0013" level="2">Rice Transformation</heading><p id="p-0070" num="0067">Plasmids pUbi-MYBS2, pUbi-MYBS2 RNAi, MYBS2-CAS9/pRGEB331 (SEQ ID NO: 16) and pUbi-MYBS2(tr)(see Alan H. Christensen and Peter H. Quail, (1996), <i>Transgenic Research</i>, volume 5, pages 213-218; ROBERT KAY et al., (1987), Science, Vol. 236, Issue 4806, pp. 1299-1302) were introduced into <i>Agrobacterium tumefaciens </i>strain EHA105 (Lifeasible, Cat #ACC-103), and rice (Tainung 67 (TNG67) transformation was performed.</p><heading id="h-0014" level="2">Rice Embryo Calli and Barley Aleurone Transient Expression Assays</heading><p id="p-0071" num="0068">Sample preparation and the particle bombardment transient expression assay using rice embryo calli was conducted. Error bars indicate the standard error for three replicate experiments. Plasmid pRS426, an unrelated yeast plasmid with a molecular mass similar to that of the effector plasmid, was used as the control plasmid.</p><heading id="h-0015" level="2">Real-Time Quantitative RT-PCR Analysis</heading><p id="p-0072" num="0069">Total RNA was extracted from tissues of rice seedlings with Trizol reagent (Invitrogen) and treated with RNase-free DNase I (Promega) at 37&#xb0; C. for 30 min. One to five &#x3bc;g of RNA was used for cDNA synthesis using SuperScript&#x2122; III Reverse Transcriptase (Invitrogen), and cDNA was diluted 10-fold for storage. Two microliters of cDNA was mixed with 10 &#x3bc;M of primers and 10 &#x3bc;l of Power SYBR Green PCR Master Mix reagent (Applied Biosystems), and applied to an ABI 7500 Real-Time PCR system (Applied Biosystems). The rice UBQ5 gene was used as an internal control to normalize all data.</p><heading id="h-0016" level="2">Field Trial</heading><p id="p-0073" num="0070">To evaluate grain yield in the field, 25-day-old seedlings were transplanted to soil with 25&#xd7;25 cm spacing between each plant. Seeds were harvested after ripening, dried and their yields were determined. Evaluations of grain yield in irrigated and non-irrigated fields were carried out. A total number of 26 plants of each line per plot were grown in the field, and only 12 plants in the middle were used to determine the grain yield.</p><heading id="h-0017" level="2">Statistical Analysis</heading><p id="p-0074" num="0071">In the present invention, n=30 for all experiments. Asterisks indicate significant differences (Student's t-test, *P&#x3c;0.05, **&#x3c;0.01, ***&#x3c;0.001).</p><heading id="h-0018" level="1">Example 1</heading><heading id="h-0019" level="2">MYBS2 is a Negative Regulator of Germination and Plant Growth, and Suppresses &#x3b1;Amy Expression</heading><p id="p-0075" num="0072">In this example, we first investigated the physiological function of MYBS2 in plant growth by gain- and loss-of-function analyses in transgenic rice overexpressing either MYBS2 cDNA or MYBS2 RNA interference (Ri) constructs under the control of the Ubi promoter (SEQ ID NO: 17). Levels of recombinant MYBS2 mRNAs increased by 52- to 60-fold in transgenic seedlings of two overexpressing (Ox) lines, whereas endogenous MYBS2 mRNA decreased by 50-70% in two silencing (Ri) lines, relative to the segregated wild type (sWT) (<figref idref="DRAWINGS">FIG. <b>1</b>A</figref>). We compared the phenotypes of these transgenic lines to sWT and found that germination rates in two Ox lines were reduced by 34-59%, but were unchanged in the Ri lines (<figref idref="DRAWINGS">FIG. <b>1</b>B</figref>). Moreover, seedling growth up to 14 days was delayed in Ox lines, but remained unchanged in the Ri lines (<figref idref="DRAWINGS">FIGS. <b>1</b>C, <b>1</b>D</figref>). Plant height at 90 days (i.e., directly before heading) was also shorter in Ox lines, but similar to sWT in Ri lines (<figref idref="DRAWINGS">FIGS. <b>1</b>E, <b>1</b>F</figref>).</p><heading id="h-0020" level="1">Example 2</heading><heading id="h-0021" level="2">MYBS2 Represses &#x3b1;Amy Promoter Activities Through the TA Box</heading><p id="p-0076" num="0073">The expression of &#x3b1;Amy3 in rice seedlings was suppressed in MYBS2-Ox lines (by 40-60%), but was activated in MYBS2-RNAi lines (by 5- to 6-fold) (<figref idref="DRAWINGS">FIG. <b>2</b>A</figref>). As shown in <figref idref="DRAWINGS">FIG. <b>2</b>A</figref>, overexpression of MYBS2 (full-length or truncated cDNA) suppresses the expression of &#x3b1;Amy3, while reduction of MYBS2 increases the expression of &#x3b1;Amy3. Segregated wild (sWT), MYBS2-Ox, MYBS2(54-265)-Ox, and MYBS2-Ri lines were used in this example.</p><p id="p-0077" num="0074">To understand the mechanism of MYBS2-mediated sugar repression of &#x3b1;Amy expression, we assessed the effect of MYBS1 (SEQ ID NO: 20), MYBS2 and MYBS2(Ri) (expression driven by the Ubi promoter) (<figref idref="DRAWINGS">FIG. <b>2</b>B</figref>) on the activity of promoters containing the &#x3b1;Amy3 SRC and six tandem repeats of the TA box (6&#xd7;TA) individually fused to the CaMV35S minimal promoter using a rice embryo transient expression system. Our results showed that the activity of the two promoters were enhanced by MYBS1, and even more significantly enhanced by the MYBS2 Ri construct, but were repressed by MYBS2 (<figref idref="DRAWINGS">FIG. <b>2</b>C</figref>). These gain- and loss-of-function analyses suggest that MYBS2 is a transcriptional repressor and that it offsets the transcriptional trans-activation activity of MYBS1 on the TA box of &#x3b1;Amy3 SRC promoters.</p><p id="p-0078" num="0075">Through transient expression assays, we found that &#x3b1;Amy3 and the 6&#xd7;TA box promoters were suppressed (by 50%) by MYBS2 overexpression, and activated (by 2.2- to 3.7-fold) by MYBS2(Ri) (<figref idref="DRAWINGS">FIG. <b>2</b></figref> C). This result is consistent with that in the transgenic stable expression assays, in which &#x3b1;Amy3 mRNA accumulation was suppressed (by 40-60%) by MYBS2 overexpression, and activated (by 5.4- to 5.7-fold) by MYBS2(Ri) (<figref idref="DRAWINGS">FIG. <b>2</b>A</figref>).</p><heading id="h-0022" level="1">Example 3</heading><heading id="h-0023" level="2">Reduced MYBS2 Expression Upregulates &#x3b1;Amy3 Under Abiotic Stress, and Ectopic Expression of &#x3b1;Amy3 Enhances Osmotic Stress Tolerance in Rice</heading><p id="p-0079" num="0076">Since &#x3b1;Amy is activated by various biotic and abiotic stresses such as water stress, viral/bacterial infection, wounding, heat, or ABA in different plant species, we investigated whether MYBS2 regulates &#x3b1;Amy3 expression in response to abiotic stresses. We found that expression of MYBS2 in rice seedlings was suppressed by dehydration (air drying) (by 70%) and heat (42&#xb0; C.) (by 80%), with the concomitant dramatic activation of &#x3b1;Amy3 expression under conditions of dehydration (by 95-fold) 390 and heat stress (by 2478-fold) (<figref idref="DRAWINGS">FIG. <b>3</b>A</figref>).</p><p id="p-0080" num="0077">To determine whether expression of &#x3b1;Amy3 is related to plant stress responses, we generated transgenic rice carrying Ubi: &#x3b1;Amy3 or &#x3b1;Amy3: &#x3b1;Amy3. We found that germination rates and shoot length of seedlings of all &#x3b1;Amy3-Ox lines were similar to sWT without sorbitol treatment (<figref idref="DRAWINGS">FIG. <b>3</b>B-D</figref>) but were significantly greater than sWT under sorbitol treatment (i.e., mimicking osmotic stress) (<figref idref="DRAWINGS">FIG. <b>3</b>E-G</figref>), indicating that ectopic expression of &#x3b1;Amy3 confers osmotic stress tolerance on rice.</p><p id="p-0081" num="0078">In this example, we show that expression of MYBS2 is suppressed whereas that of &#x3b1;Amy3 is induced by dehydration and heat in rice seedlings (<figref idref="DRAWINGS">FIG. <b>3</b>A</figref>). The results indicate that sugar production via &#x3b1;Amy-mediated starch degradation may be involved in stress tolerance in rice. This notion is supported by our analysis showing that ectopic overexpression of &#x3b1;Amy3 promotes the germination rate and seedling growth of rice under osmotic stress (<figref idref="DRAWINGS">FIGS. <b>3</b>E-G</figref>).</p><heading id="h-0024" level="1">Example 4</heading><heading id="h-0025" level="2">Reduced MYBS2 Expression Enhances Osmotic and Drought Stress Tolerance and Grain Yield in Rice</heading><p id="p-0082" num="0079">To further investigate whether down-regulation of MYBS2 improves plant stress tolerance, we subjected the MYBS2-Ox, MYBS2(54-265)-Ox and MYBS2-Ri lines to abiotic stress treatments. Using PEG treatment to mimic osmotic stress, we observed that the survival rate of the MYBS2-Ri lines (100%) were twice that of the MYBS2-Ox lines (40-50%) and higher than that for the sWT (90%) (<figref idref="DRAWINGS">FIG. <b>4</b>A</figref>). Upon drought treatment in soil, the survival rate of the MYBS2-Ri lines (100%) was significantly greater than that of the sWT line (70%), and dramatically greater than that of the MYBS2-Ox lines (0-17%) and MYBS2(54-265)-Ox lines (0-10%) (<figref idref="DRAWINGS">FIG. <b>4</b>B</figref>). Deletion of the N-terminal amino acid residues 1-53 caused exclusively nuclear localization of MYBS2, which is consistent with the very low expression of &#x3b1;Amy3 in rice seedlings (<figref idref="DRAWINGS">FIG. <b>2</b>A</figref>) and the reduced survival rate of seedlings under drought stress (<figref idref="DRAWINGS">FIG. <b>4</b>B</figref>). Since we had found that MYBS2 impairs seedling and plant growth (<figref idref="DRAWINGS">FIGS. <b>1</b>C, <b>1</b>E</figref>), we also evaluated the impact of MYBS2 expression on grain yield in field trials. These lines were grown in irrigated open field (<figref idref="DRAWINGS">FIG. <b>4</b>D</figref>) or greenhouse in Spring (February to June) (<figref idref="DRAWINGS">FIG. <b>4</b>E</figref>) or Fall (July to November)(<figref idref="DRAWINGS">FIG. <b>4</b>F</figref>) season. We observed that grain yields were reduced by 40-70% for the MYBS2-Ox lines, but increased by 26-54% in the MYBS2-Ri lines, relative to the sWT (<figref idref="DRAWINGS">FIG. <b>4</b>C</figref>). In addition, relative to the sWT, grain weight was increased by 106-135% in the MYBS2-Ri lines (i.e., RNAi-1 and RNAi-2 in <figref idref="DRAWINGS">FIG. <b>4</b>G</figref>) and the MYBS2-Cas9 (knock out) lines (i.e., Cas9-1 and Cas9-2 in <figref idref="DRAWINGS">FIG. <b>4</b>G</figref>). Together, these findings demonstrate that MYBS2 is a negative regulator of abiotic stress tolerance and grain yield.</p><p id="p-0083" num="0080">Although reduced expression of MYBS2 does not affect plant growth under normal growth conditions (<figref idref="DRAWINGS">FIGS. <b>1</b>D, <b>1</b>F</figref>), it does promote osmotic and drought tolerance in transgenic rice plants, whereas overexpression of MYBS2 has the opposite effect (<figref idref="DRAWINGS">FIGS. <b>4</b>A, <b>4</b>B</figref>).</p><heading id="h-0026" level="1">Example 5</heading><p id="p-0084" num="0081">Overexpression of MYBS2 Reduces the Chalky Grains while Reduced Expression of MYBS2 (or Overexpression of &#x3b1;Amy3) Increases the Chalky Grains</p><p id="p-0085" num="0082">We also evaluated the impact of MYBS2 expression and its downstream target &#x3b1;Amy3 expression on grain (obtained from Example 4) quality. Our recent studies indicated that overexpression of MYBS2 can improve the seed quality by producing less-chalky seeds. In contrast, reduced expression of MYBS2 or increased expression of &#x3b1;AMY3 produced chalky grain (<figref idref="DRAWINGS">FIG. <b>5</b></figref>, in which ox means MYBS2 overexpression lines; Ubi-Amy3 means using Ubi as the promoter; Amy3p-&#x3b1;Amy3 means using the promoter of &#x3b1;Amy3D).</p><p id="p-0086" num="0083">In summary, the present invention providing a method for improving growth, stress tolerance and productivity of a plant, and a method for increasing seed quality of a plant has the benefits on promoting plant growth and/or yield under normal or stressed conditions to cope with global water shortage in farmland and global climate warming, protecting plants from damages caused by water deficit, maintaining grain productivity under non-stressed and stressed conditions, maintaining high quality rice grain under global warming, enhancing public acceptance of new varieties and their products, reducing the transparency of milled rice to provide good sake-brewing rice for wine industry, enhancing transparency of milled rice for global market demand for high quality rice, maintaining the sugar homeostasis in plant, increasing sugar contents and stress tolerance, and generating new varieties to drought in various plant species.</p><p id="p-0087" num="0084">Although the present invention has been described with reference to the preferred embodiments, it will be apparent to those skilled in the art that a variety of modifications and changes in form and detail may be made without departing from the scope of the present invention defined by the appended claims.</p><?detailed-description description="Detailed Description" end="tail"?></description><us-sequence-list-doc id="SEQLST-1"><sequence-list file="US20230002778A1-20230105-S00001.XML" carriers="internal-electronic" seq-file-type="ST.25"/></us-sequence-list-doc><us-claim-statement>What is claimed is:</us-claim-statement><claims id="claims"><claim id="CLM-00001" num="00001"><claim-text><b>1</b>. A method for improving growth, stress tolerance and productivity of a plant, comprising:<claim-text>(a) providing a transgenic plant, which includes a reduced expression on an MYBS2 gene as relative to its wild-type counterpart; and</claim-text><claim-text>(b) growing the transgenic plant in a normal environment or an environment comprising an abiotic stress factor.</claim-text></claim-text></claim><claim id="CLM-00002" num="00002"><claim-text><b>2</b>. The method according to <claim-ref idref="CLM-00001">claim 1</claim-ref>, wherein the transgenic plant further includes an increased expression on an &#x3b1;Amy3 gene as relative to its wild-type counterpart.</claim-text></claim><claim id="CLM-00003" num="00003"><claim-text><b>3</b>. The method according to <claim-ref idref="CLM-00002">claim 2</claim-ref>, wherein the MYBS2 gene encodes an MYBS2 transcription factor, and the MYBS2 transcription factor binds to a TA box in a promoter of the &#x3b1;Amy3 gene.</claim-text></claim><claim id="CLM-00004" num="00004"><claim-text><b>4</b>. The method according to <claim-ref idref="CLM-00001">claim 1</claim-ref>, wherein the plant is a monocotyledonous plant or a dicotyledonous plant.</claim-text></claim><claim id="CLM-00005" num="00005"><claim-text><b>5</b>. The method according to <claim-ref idref="CLM-00004">claim 4</claim-ref>, wherein the monocotyledonous plant is selected from the group consisting of <i>Zea mays, Sorghum bicolor, Setaria italica, Hordeum vulgare, Brachypodium distachyon, Oryza sativa, Triticum </i>spp., and <i>Saccharum </i>spp.</claim-text></claim><claim id="CLM-00006" num="00006"><claim-text><b>6</b>. The method according to <claim-ref idref="CLM-00004">claim 4</claim-ref>, wherein the dicotyledonous plant is selected from the group consisting of <i>Cucumis sativus, Ricinus communis, Solanum lycopersicum, Solanum tuberosum, Vitis vinifera, Populus trichocarpa, Arabidopsis thaliana, Arabidopsis lyrata</i>, and <i>Platycodon grandiflorus. </i></claim-text></claim><claim id="CLM-00007" num="00007"><claim-text><b>7</b>. The method according to <claim-ref idref="CLM-00001">claim 1</claim-ref>, wherein the plant is a crop.</claim-text></claim><claim id="CLM-00008" num="00008"><claim-text><b>8</b>. The method according to <claim-ref idref="CLM-00007">claim 7</claim-ref>, wherein the crop is rice, maize, wheat, barley, sugarcane, banana, cotton, soybean, pea, potato, tomato, brassica, orchid, balloon flower, yam, sweet potato, cassava, rose, petunia, chrysanthemum, lily, or carnation.</claim-text></claim><claim id="CLM-00009" num="00009"><claim-text><b>9</b>. The method according to <claim-ref idref="CLM-00001">claim 1</claim-ref>, wherein the plant is an angiosperm.</claim-text></claim><claim id="CLM-00010" num="00010"><claim-text><b>10</b>. The method according to <claim-ref idref="CLM-00001">claim 1</claim-ref>, wherein the abiotic stress factor is osmotic stress, salt, dehydration, or heat.</claim-text></claim><claim id="CLM-00011" num="00011"><claim-text><b>11</b>. A method for increasing seed quality of a plant, comprising:<claim-text>(a) providing a seed from a transgenic plant, which overexpresses a full-length MYBS2 gene or a mutant MYBS2 gene as relative to its wild-type counterpart; and</claim-text><claim-text>(b) growing the seed in a normal environment or an environment comprising an abiotic stress factor.</claim-text></claim-text></claim><claim id="CLM-00012" num="00012"><claim-text><b>12</b>. The method according to <claim-ref idref="CLM-00011">claim 11</claim-ref>, wherein the seed includes a reduced expression on an &#x3b1;Amy3 gene as relative to its wild-type counterpart.</claim-text></claim><claim id="CLM-00013" num="00013"><claim-text><b>13</b>. The method according to <claim-ref idref="CLM-00011">claim 11</claim-ref>, wherein the mutant MYBS2 gene encodes a truncated MYBS2 transcription factor which includes deletion of 1st-53rd amino acid residues.</claim-text></claim><claim id="CLM-00014" num="00014"><claim-text><b>14</b>. The method according to <claim-ref idref="CLM-00011">claim 11</claim-ref>, wherein the plant is a monocotyledonous plant or a dicotyledonous plant.</claim-text></claim><claim id="CLM-00015" num="00015"><claim-text><b>15</b>. The method according to <claim-ref idref="CLM-00014">claim 14</claim-ref>, wherein the monocotyledonous plant is selected from the group consisting of <i>Zea mays, Sorghum bicolor, Setaria italica, Hordeum vulgare, Brachypodium distachyon, Oryza sativa, Triticum </i>spp., and <i>Saccharum </i>spp.</claim-text></claim><claim id="CLM-00016" num="00016"><claim-text><b>16</b>. The method according to <claim-ref idref="CLM-00014">claim 14</claim-ref>, wherein the dicotyledonous plant is selected from the group consisting of <i>Cucumis sativus, Ricinus communis, Solanum lycopersicum, Solanum tuberosum, Vitis vinifera, Populus trichocarpa, Arabidopsis thaliana, Arabidopsis lyrata</i>, and <i>Platycodon grandiflorus. </i></claim-text></claim><claim id="CLM-00017" num="00017"><claim-text><b>17</b>. The method according to <claim-ref idref="CLM-00011">claim 11</claim-ref>, wherein the plant is a crop.</claim-text></claim><claim id="CLM-00018" num="00018"><claim-text><b>18</b>. The method according to <claim-ref idref="CLM-00017">claim 17</claim-ref>, wherein the crop is rice, maize, wheat, barley, sugarcane, banana, cotton, soybean, pea, potato, tomato, brassica, orchid, balloon flower, yam, sweet potato, cassava, rose, petunia, chrysanthemum, lily, or carnation.</claim-text></claim><claim id="CLM-00019" num="00019"><claim-text><b>19</b>. The method according to <claim-ref idref="CLM-00011">claim 11</claim-ref>, wherein the plant is an angiosperm.</claim-text></claim><claim id="CLM-00020" num="00020"><claim-text><b>20</b>. The method according to <claim-ref idref="CLM-00011">claim 11</claim-ref>, wherein the abiotic stress factor is osmotic stress, salt, dehydration, or heat.</claim-text></claim></claims></us-patent-application>